Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
122227 1351 27 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
3825 1351 27 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
644 1351 27 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
CHEMBL264100 1351 27 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
44323260 106532 0 None - 1 Rat 6.0 pEC50 = 6.0 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL 845 32 10 10 0.7 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O 10.1016/S0960-894X(97)10042-7
CHEMBL315388 106532 0 None - 1 Rat 6.0 pEC50 = 6.0 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL 845 32 10 10 0.7 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O 10.1016/S0960-894X(97)10042-7
11757682 121526 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assayAntagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121526 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assayAntagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11214480 148647 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 514 7 4 5 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccc(CCC3=NCCN3)cc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL394370 148647 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 514 7 4 5 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccc(CCC3=NCCN3)cc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
57397292 69716 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939758 69716 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
54772237 65452 0 None 6 2 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65452 0 None 6 2 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
60142570 125394 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
CHEMBL3648475 125394 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
60142706 125399 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648480 125399 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
11570120 69713 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939755 69713 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
24970287 187839 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL502140 187839 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
46230121 200458 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 9 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL609157 200458 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 9 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46230161 199735 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 561 7 2 10 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL604735 199735 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 561 7 2 10 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54582655 61867 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777969 61867 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587189 171875 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
CHEMBL447870 171875 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
56594769 65395 0 None 6 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65395 0 None 6 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
665 959 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
9916412 959 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
CHEMBL189123 959 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
665 959 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 959 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 959 2 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
46216675 198925 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 513 5 2 7 4.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCC(F)(F)CC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL599285 198925 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 513 5 2 7 4.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCC(F)(F)CC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
46230160 198897 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 10 2.7 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599153 198897 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 10 2.7 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
11387387 61865 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777967 61865 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
57523216 125395 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648476 125395 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
60142962 125407 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
CHEMBL3648488 125407 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
60142963 125408 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125408 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60143095 125409 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648490 125409 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
60141038 125413 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648494 125413 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
60141185 125421 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648502 125421 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
60141464 125427 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
CHEMBL3648508 125427 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
60141466 125429 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
CHEMBL3648510 125429 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
57398978 69715 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939757 69715 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
53248885 61856 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777958 61856 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
53248885 61856 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777958 61856 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57396447 69761 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 5 2 5 2.2 CN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939944 69761 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 5 2 5 2.2 CN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
57400696 69717 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939759 69717 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57392941 69756 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 6 2 5 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939939 69756 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 6 2 5 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11442712 84802 0 None 9 2 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84802 0 None 9 2 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46230120 197530 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 9 3.9 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL589820 197530 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 9 3.9 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46230203 198965 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 7 3.6 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599574 198965 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 7 3.6 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
57395448 69714 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939756 69714 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57398238 69758 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939941 69758 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2011.11.112
57391173 69760 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.2 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939943 69760 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.2 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
46230404 198675 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 492 6 2 7 5.2 CC(=O)Nn1c(Cl)cnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL597747 198675 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 492 6 2 7 5.2 CC(=O)Nn1c(Cl)cnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
56589598 65451 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65451 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
11214819 61848 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777885 61848 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142704 125397 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648478 125397 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60143096 125410 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648491 125410 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60141324 125424 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648505 125424 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57401664 69759 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 3 5 1.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939942 69759 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 3 5 1.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
11342704 61854 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777956 61854 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54586519 61875 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777977 61875 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587188 192768 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
CHEMBL525092 192768 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
54583617 61866 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777968 61866 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57390218 69718 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939760 69718 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16108961 910 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 910 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 910 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142703 125396 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648477 125396 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60141041 125415 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
CHEMBL3648496 125415 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
60141182 125418 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648499 125418 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
71229238 125422 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648503 125422 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
60141323 125423 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648504 125423 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57392940 69748 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 434 5 2 5 1.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939931 69748 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 434 5 2 5 1.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
46230119 197529 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 8 4.5 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL589819 197529 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 8 4.5 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54581635 61849 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777886 61849 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
53360054 69746 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939929 69746 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
16747694 87525 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234097 87525 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
46230163 198726 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 6 4.7 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL598124 198726 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 6 4.7 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
11364466 61844 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777881 61844 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11341479 61876 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777978 61876 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587186 172149 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL450541 172149 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
54587514 61846 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777883 61846 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46230990 198956 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 473 7 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(CF)CF)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL599490 198956 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 473 7 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(CF)CF)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
60142303 125381 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648462 125381 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142304 125382 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648463 125382 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142437 125385 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648466 125385 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142440 125387 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648468 125387 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142834 125402 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
CHEMBL3648483 125402 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
60142836 125404 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
CHEMBL3648485 125404 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
60141465 125428 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648509 125428 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
57398235 69750 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 462 7 2 5 2.0 CCCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939933 69750 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 462 7 2 5 2.0 CCCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
11168954 61845 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777882 61845 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188125 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL504531 188125 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188125 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL504531 188125 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
46216847 198756 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 559 8 2 11 5.4 COc1cc(C(=O)Nc2nsnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL598349 198756 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 559 8 2 11 5.4 COc1cc(C(=O)Nc2nsnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
54581667 61873 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777975 61873 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142028 125373 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648455 125373 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142438 125386 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648467 125386 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142835 125403 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648484 125403 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60142963 125408 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125408 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
54772237 65452 0 None -6 2 Rabbit 9.2 pIC50 = 9.2 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65452 0 None -6 2 Rabbit 9.2 pIC50 = 9.2 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
57396446 69749 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 448 6 2 5 1.6 CCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939932 69749 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 448 6 2 5 1.6 CCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
46230202 198578 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 7 4.1 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL597115 198578 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 7 4.1 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54581634 61847 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777884 61847 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
10239095 83501 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL220657 83501 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
57398237 69757 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2011.11.112
CHEMBL1939940 69757 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2011.11.112
46230309 197796 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 591 8 2 10 6.0 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc3ccccc32)on1 10.1016/j.bmcl.2009.11.120
CHEMBL591676 197796 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 591 8 2 10 6.0 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc3ccccc32)on1 10.1016/j.bmcl.2009.11.120
57398236 69755 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 6 2 5 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939938 69755 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 6 2 5 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11477390 84737 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
CHEMBL225218 84737 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
46230941 199577 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 463 5 2 7 3.7 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL603907 199577 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 463 5 2 7 3.7 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
54587552 61864 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777966 61864 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
16221282 85112 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL227713 85112 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587181 188092 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL503847 188092 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16221282 85112 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85112 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
25105469 186478 6 None 2 2 Rat 9.1 pIC50 = 9.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
CHEMBL491198 186478 6 None 2 2 Rat 9.1 pIC50 = 9.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
60142567 125391 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648472 125391 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
11386138 84020 0 None 8 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84020 0 None 8 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44587183 172655 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL452331 172655 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
57403391 69751 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 476 7 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939934 69751 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 476 7 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
10217706 82812 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
CHEMBL218605 82812 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
11363856 84114 0 None 13 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84114 0 None 13 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
11215488 61852 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777954 61852 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46230067 197807 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 541 5 2 4 4.8 CCN(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL591742 197807 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 541 5 2 4 4.8 CCN(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
46230939 198598 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 5 2 7 3.2 CC(C)N(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL597235 198598 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 5 2 7 3.2 CC(C)N(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
46216846 199544 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 543 8 2 11 4.9 COc1cc(C(=O)Nc2nonc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL603668 199544 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 543 8 2 11 4.9 COc1cc(C(=O)Nc2nonc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
56594642 65392 0 None 21 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65392 0 None 21 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
44587182 188105 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL504119 188105 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
57394684 69753 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 510 7 2 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(Cc3ccccc3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939936 69753 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 510 7 2 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(Cc3ccccc3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
56594772 65450 0 None 15 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65450 0 None 15 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
56594769 65395 0 None -6 2 Rabbit 9.0 pIC50 = 9.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65395 0 None -6 2 Rabbit 9.0 pIC50 = 9.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57394685 69754 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 6 2 5 1.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939937 69754 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 6 2 5 1.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44430696 87524 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234096 87524 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
11225601 141495 0 None 3 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141495 0 None 3 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
46230833 197583 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 4 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590150 197583 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 4 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
54580628 61842 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777879 61842 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11272685 61869 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777971 61869 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587041 187294 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL496459 187294 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
54585540 61874 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777976 61874 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
46229967 197859 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 537 6 2 3 5.1 C[C@H]1CC[C@@H](C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL592239 197859 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 537 6 2 3 5.1 C[C@H]1CC[C@@H](C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
46230162 199632 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 6 5.2 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL604177 199632 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 6 5.2 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46911683 15065 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 629 10 2 4 6.6 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210756 15065 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 629 10 2 4 6.6 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1016/j.bmcl.2010.06.010
57403390 69738 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 489 5 2 6 1.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCS(=O)(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939921 69738 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 489 5 2 6 1.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCS(=O)(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
57394683 69752 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 490 6 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939935 69752 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 490 6 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44421279 84732 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225133 84732 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46230940 198599 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 451 4 2 7 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(C)(C)C)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL597236 198599 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 451 4 2 7 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(C)(C)C)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
44587184 169587 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL444431 169587 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11284304 61870 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777972 61870 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57401663 69737 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 455 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939920 69737 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 455 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
11167607 136821 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL375288 136821 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46216844 198987 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 4 5.5 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599779 198987 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 4 5.5 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
16102897 86811 13 None - 1 Human 8.8 pIC50 = 8.8 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86811 13 None - 1 Human 8.8 pIC50 = 8.8 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
17751347 69770 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 4 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC3(CCN(C)C3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939953 69770 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 4 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC3(CCN(C)C3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
46230403 198652 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 458 6 2 7 4.5 CC(=O)Nn1ccnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL597546 198652 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 458 6 2 7 4.5 CC(=O)Nn1ccnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
46230459 197541 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 476 6 2 8 5.1 CC(=O)Nc1nsnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL589900 197541 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 476 6 2 8 5.1 CC(=O)Nc1nsnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
46230352 198730 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 2 10 4.8 COc1cc(C(=O)Nn2ccnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL598147 198730 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 2 10 4.8 COc1cc(C(=O)Nn2ccnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
44587185 188351 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL508043 188351 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11342350 61850 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777887 61850 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46216845 198989 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 530 7 2 4 5.0 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599780 198989 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 530 7 2 4 5.0 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
23630715 152121 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 550 7 3 5 4.0 CN1CCC(N2CCC(CCNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
CHEMBL397248 152121 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 550 7 3 5 4.0 CN1CCC(N2CCC(CCNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
10151875 136455 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL374580 136455 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10031511 16765 0 None 1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16765 0 None 1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
23630813 151278 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 560 5 4 5 4.1 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1F 10.1021/jm051292n
CHEMBL396524 151278 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 560 5 4 5 4.1 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1F 10.1021/jm051292n
16221282 85112 0 None -13 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85112 0 None -13 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
16221111 85114 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227721 85114 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11215913 136016 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL373654 136016 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
16220918 160923 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
CHEMBL412762 160923 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
44579766 192644 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 423 6 1 5 3.7 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL523773 192644 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 423 6 1 5 3.7 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
49863234 15060 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210751 15060 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44561641 186142 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488677 186142 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11635365 173989 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 173989 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
11635365 173989 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
CHEMBL455642 173989 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
11214998 76202 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206247 76202 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44428100 153010 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 396 3 2 4 4.5 Cc1nc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cs1 10.1021/jm051292n
CHEMBL398008 153010 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 396 3 2 4 4.5 Cc1nc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cs1 10.1021/jm051292n
56594241 65546 0 None 4 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65546 0 None 4 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220987 78702 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL2113274 78702 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
54587551 61859 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777961 61859 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44580012 186463 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 495 8 1 6 4.6 CN(Cc1ccc(-c2nccs2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491041 186463 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 495 8 1 6 4.6 CN(Cc1ccc(-c2nccs2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
24946441 186551 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 6 0 6 2.9 CN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491829 186551 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 6 0 6 2.9 CN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
60142169 125379 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648460 125379 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
56835163 69225 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69225 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
23630613 91651 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 607 8 2 7 5.4 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccn1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL241937 91651 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 607 8 2 7 5.4 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccn1)c1ccccc1Cl 10.1021/jm051292n
11363856 84114 0 None -13 2 Rabbit 7.9 pIC50 = 7.9 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84114 0 None -13 2 Rabbit 7.9 pIC50 = 7.9 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
23630920 92517 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 636 9 2 7 6.0 COc1ccc(-n2nc(C(=O)NCCC3CCN(c4ccncc4)CC3)c(Br)c2NC(=O)c2ccccc2Cl)cc1 10.1021/jm051292n
CHEMBL244093 92517 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 636 9 2 7 6.0 COc1ccc(-n2nc(C(=O)NCCC3CCN(c4ccncc4)CC3)c(Br)c2NC(=O)c2ccccc2Cl)cc1 10.1021/jm051292n
17751599 69747 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939930 69747 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
57401425 69220 0 None -1 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69220 0 None -1 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
25207727 197757 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 435 6 2 5 2.6 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL591354 197757 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 435 6 2 5 2.6 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
16221054 141540 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
CHEMBL387982 141540 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
11284458 140058 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
CHEMBL381366 140058 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
11284458 140058 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
CHEMBL381366 140058 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
23631903 92357 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 531 6 4 6 3.7 Nc1cccc(N2CCC(CNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)n1 10.1021/jm051292n
CHEMBL243680 92357 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 531 6 4 6 3.7 Nc1cccc(N2CCC(CNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)n1 10.1021/jm051292n
11284458 140058 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381366 140058 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44561786 172094 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL449789 172094 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
17751422 69763 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939946 69763 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
11420875 76984 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL208387 76984 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
44579811 186284 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 1 6 2.8 CCC(NC(=O)c1nc2ccccc2n1Cc1ccccc1)C(=O)N1CCN(C2CCN(C)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL489588 186284 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 1 6 2.8 CCC(NC(=O)c1nc2ccccc2n1Cc1ccccc1)C(=O)N1CCN(C2CCN(C)CC2)CC1 10.1016/j.bmcl.2008.08.014
60142707 125400 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648481 125400 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
54580655 61860 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777962 61860 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57399887 69769 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 466 4 1 5 1.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2C[C@@H]3CN(C)C[C@@H]3C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939952 69769 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 466 4 1 5 1.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2C[C@@H]3CN(C)C[C@@H]3C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
56672397 65542 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human B1 receptor by cell-based assayAntagonist activity at human B1 receptor by cell-based assay
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
CHEMBL1835752 65542 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human B1 receptor by cell-based assayAntagonist activity at human B1 receptor by cell-based assay
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
57399671 69226 0 None -2 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69226 0 None -2 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
44579943 186214 0 None - 1 Crab-eating macaque 7.9 pIC50 = 7.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 6 3.2 CN(Cc1ccc(C2=NCCN2C)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489191 186214 0 None - 1 Crab-eating macaque 7.9 pIC50 = 7.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 6 3.2 CN(Cc1ccc(C2=NCCN2C)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108965 160783 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL412552 160783 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
16221057 142488 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389478 142488 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
16221161 143789 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL390539 143789 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
44410313 75449 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL204847 75449 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11685446 186122 0 None -14 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186122 0 None -14 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
56594771 65449 0 None 2 2 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65449 0 None 2 2 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
46230069 199340 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 555 5 2 4 5.2 CC(C)N(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL602320 199340 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 555 5 2 4 5.2 CC(C)N(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
49863229 15055 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210746 15055 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44579828 192703 0 None 1 2 Rat 7.8 pIC50 = 7.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL524126 192703 0 None 1 2 Rat 7.8 pIC50 = 7.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57399886 69765 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939948 69765 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
49863231 15057 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210748 15057 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44579795 186362 0 None -30 2 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490201 186362 0 None -30 2 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44579828 192703 0 None -1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL524126 192703 0 None -1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11317669 148807 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 481 5 3 4 3.2 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N1CCCCC1 10.1021/jm051292n
CHEMBL394514 148807 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 481 5 3 4 3.2 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N1CCCCC1 10.1021/jm051292n
11204003 76868 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
CHEMBL207947 76868 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
665 959 2 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 959 2 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 959 2 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
44410328 75652 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL205501 75652 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
23630615 92678 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 601 10 2 7 4.5 CN(C)CCn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL244284 92678 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 601 10 2 7 4.5 CN(C)CCn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL3038104 209192 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)O)C1CCCCC1 10.1021/jm950716i
16220917 165782 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL427279 165782 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221056 85134 0 None -97 2 Rabbit 5.8 pIC50 = 5.8 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85134 0 None -97 2 Rabbit 5.8 pIC50 = 5.8 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
46230834 197584 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 6 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590151 197584 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 6 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
46230893 198688 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 7 2.4 CN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL597840 198688 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 7 2.4 CN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
57390932 69215 0 None 14 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69215 0 None 14 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220916 85135 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227879 85135 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16108961 910 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 910 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 910 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
11526891 188291 0 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188291 0 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
16221056 85134 0 None 97 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85134 0 None 97 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
60141326 125425 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648506 125425 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
56594772 65450 0 None -15 2 Rabbit 7.8 pIC50 = 7.8 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65450 0 None -15 2 Rabbit 7.8 pIC50 = 7.8 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57396445 69742 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 419 5 2 4 2.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939925 69742 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 419 5 2 4 2.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11213709 91891 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 475 6 4 4 3.0 NC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL242994 91891 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 475 6 4 4 3.0 NC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
16108964 141189 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385741 141189 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57398979 69722 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)C(NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1)CCC2 10.1016/j.bmcl.2011.11.112
CHEMBL1939764 69722 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)C(NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1)CCC2 10.1016/j.bmcl.2011.11.112
44579830 186410 0 None 1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490619 186410 0 None 1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57390219 69725 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 441 5 2 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939767 69725 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 441 5 2 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
46230258 198755 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 486 6 2 7 5.2 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc(C)c1C 10.1016/j.bmcl.2009.11.120
CHEMBL598348 198755 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 486 6 2 7 5.2 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc(C)c1C 10.1016/j.bmcl.2009.11.120
11512379 165452 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
CHEMBL425416 165452 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
11342079 161237 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL414091 161237 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57392728 69224 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934263 69224 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44579890 186034 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 534 7 1 6 3.9 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)C1CCN(C(=O)c2nc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL487909 186034 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 534 7 1 6 3.9 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)C1CCN(C(=O)c2nc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.bmcl.2008.08.014
57403175 69219 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934258 69219 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
57394686 69764 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 5 1 5 2.0 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939947 69764 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 5 1 5 2.0 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
16221108 85106 0 None 22 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85106 0 None 22 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
44579969 186318 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 509 9 1 5 4.5 CN(Cc1ccc(CN2CCCCC2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489810 186318 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 509 9 1 5 4.5 CN(Cc1ccc(CN2CCCCC2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44580043 184159 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 460 6 1 5 3.6 O=C(NCCC(=O)N1CCC2(CCOCC2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL485079 184159 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 460 6 1 5 3.6 O=C(NCCC(=O)N1CCC2(CCOCC2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
25105469 186478 6 None -2 2 Crab-eating macaque 8.7 pIC50 = 8.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
CHEMBL491198 186478 6 None -2 2 Crab-eating macaque 8.7 pIC50 = 8.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
60142027 125372 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648454 125372 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
54584600 61863 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777965 61863 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56589598 65451 0 None -7 2 Rabbit 8.7 pIC50 = 8.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65451 0 None -7 2 Rabbit 8.7 pIC50 = 8.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
46230835 199316 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 439 4 2 6 4.6 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL602115 199316 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 439 4 2 6 4.6 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
25195622 61853 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
CHEMBL1777955 61853 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
54587553 61877 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777979 61877 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142441 125390 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648471 125390 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
11442712 84802 0 None -9 2 Rabbit 8.6 pIC50 = 8.6 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84802 0 None -9 2 Rabbit 8.6 pIC50 = 8.6 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
54581666 61868 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777970 61868 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57399382 69511 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 1 5 2.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1938412 69511 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 1 5 2.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
60141042 125416 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
CHEMBL3648497 125416 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
11663809 173029 0 None -5 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173029 0 None -5 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
16221228 165464 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL425490 165464 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
57398239 69762 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939945 69762 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
11526891 188291 0 None -1 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188291 0 None -1 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
23630810 143969 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 452 7 3 5 3.7 O=C(NCCC1CCN(c2ccncc2)CC1)c1cc(NC(=O)c2ccccc2Cl)[nH]n1 10.1021/jm051292n
CHEMBL390692 143969 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 452 7 3 5 3.7 O=C(NCCC1CCN(c2ccncc2)CC1)c1cc(NC(=O)c2ccccc2Cl)[nH]n1 10.1021/jm051292n
137657568 159001 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1920 23 21 26 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N2 10.1021/acs.jmedchem.6b01011
CHEMBL4102547 159001 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1920 23 21 26 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N2 10.1021/acs.jmedchem.6b01011
16220988 85110 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
CHEMBL227697 85110 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
11405561 91775 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 354 4 3 3 3.9 Cc1c(C(=O)Nc2ccccc2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL242565 91775 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 354 4 3 3 3.9 Cc1c(C(=O)Nc2ccccc2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
16221053 141817 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL388720 141817 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
16220986 137092 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL375709 137092 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
17751868 69743 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 393 5 2 5 0.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939926 69743 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 393 5 2 5 0.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2)cc1 10.1016/j.bmcl.2011.11.112
49863230 15056 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210747 15056 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
16221226 143865 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
CHEMBL390603 143865 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
70691814 73505 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
CHEMBL2018868 73505 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
23627521 73510 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018873 73510 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
56594642 65392 0 None -21 2 Rabbit 7.7 pIC50 = 7.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65392 0 None -21 2 Rabbit 7.7 pIC50 = 7.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57398980 69726 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 440 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939768 69726 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 440 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
23630510 92865 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 446 5 3 3 4.6 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL245129 92865 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 446 5 3 3 4.6 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
11635364 173990 0 None -4 2 Rabbit 6.7 pIC50 = 6.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 173990 0 None -4 2 Rabbit 6.7 pIC50 = 6.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
44410186 76864 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL207945 76864 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
16220914 85143 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL228014 85143 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44580013 186464 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 2 5 3.9 CN(Cc1ccc(-c2ccn[nH]2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491042 186464 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 2 5 3.9 CN(Cc1ccc(-c2ccn[nH]2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11444165 140348 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
CHEMBL381979 140348 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
60142024 125369 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648451 125369 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
49863233 15059 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210750 15059 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44587207 187565 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL498489 187565 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
23630811 91892 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 470 7 3 5 3.9 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1F)c1ccccc1Cl 10.1021/jm051292n
CHEMBL242995 91892 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 470 7 3 5 3.9 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1F)c1ccccc1Cl 10.1021/jm051292n
44579830 186410 0 None -1 2 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490619 186410 0 None -1 2 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57394688 69767 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 5 1 5 2.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939950 69767 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 5 1 5 2.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
11307733 74547 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL203174 74547 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44579866 192583 0 None - 1 Crab-eating macaque 5.6 pIC50 = 5.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 5 0 6 3.7 O=C(c1nc2ccccc2n1Cc1ccccc1)N1CCC(C(=O)N2CCN(c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL523266 192583 0 None - 1 Crab-eating macaque 5.6 pIC50 = 5.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 5 0 6 3.7 O=C(c1nc2ccccc2n1Cc1ccccc1)N1CCC(C(=O)N2CCN(c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
54585539 61871 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777973 61871 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54585539 61871 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777973 61871 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
56835163 69225 0 None -1 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69225 0 None -1 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
16220990 85121 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227786 85121 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
60142167 125376 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
CHEMBL3648458 125376 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
88925471 125384 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648465 125384 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142305 125383 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648464 125383 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44410143 76983 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
CHEMBL208386 76983 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
54587550 61857 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777959 61857 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57390932 69215 0 None -14 2 Rabbit 6.6 pIC50 = 6.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69215 0 None -14 2 Rabbit 6.6 pIC50 = 6.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
17751827 69745 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 421 5 2 5 1.3 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939928 69745 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 421 5 2 5 1.3 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44561643 185066 0 None -5 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185066 0 None -5 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
57391172 69741 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939924 69741 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2C)cc1 10.1016/j.bmcl.2011.11.112
71449505 80512 0 None -3 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assay
ChEMBL 475 8 1 5 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CCCc2ccc3cccnc3n2)c(F)c1 10.1016/j.bmcl.2011.04.091
CHEMBL2153436 80512 0 None -3 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assay
ChEMBL 475 8 1 5 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CCCc2ccc3cccnc3n2)c(F)c1 10.1016/j.bmcl.2011.04.091
16221225 168802 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL442056 168802 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
57401426 69223 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934262 69223 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
24946440 192450 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 6 0 6 2.4 CN1CCC(N2CCN(C(=O)CN(C)C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL522308 192450 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 6 0 6 2.4 CN1CCC(N2CCN(C(=O)CN(C)C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
44579812 186552 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 482 7 0 6 3.3 CCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491830 186552 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 482 7 0 6 3.3 CCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57390933 69216 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934255 69216 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
46229968 199700 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 538 6 2 4 4.5 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL604575 199700 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 538 6 2 4 4.5 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
23627396 73504 0 None - 1 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018867 73504 0 None - 1 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
60142166 125375 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
CHEMBL3648457 125375 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
11375297 92140 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL243467 92140 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
23630509 92838 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 453 4 4 4 2.5 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CCCCNC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL244955 92838 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 453 4 4 4 2.5 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CCCCNC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
44580044 184160 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 459 6 1 5 3.1 CN1CCC2(CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)C1 10.1016/j.bmcl.2008.08.014
CHEMBL485080 184160 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 459 6 1 5 3.1 CN1CCC2(CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)C1 10.1016/j.bmcl.2008.08.014
11620980 173140 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
CHEMBL453596 173140 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
23631902 161315 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL414892 161315 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm051292n
11215677 61855 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777957 61855 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11561240 69719 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 439 5 2 4 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939761 69719 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 439 5 2 4 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
16108961 910 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
664 910 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
CHEMBL415848 910 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
16108961 910 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 910 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 910 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142705 125398 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
CHEMBL3648479 125398 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
46230354 199778 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 3 9 5.2 COc1cc(C(=O)Nc2c[nH]nc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL604999 199778 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 3 9 5.2 COc1cc(C(=O)Nc2c[nH]nc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
23630919 142026 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 606 8 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccc1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL389097 142026 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 606 8 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccc1)c1ccccc1Cl 10.1021/jm051292n
23631902 161315 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm1000776
CHEMBL414892 161315 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm1000776
46230889 198810 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 419 4 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(C)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL598665 198810 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 419 4 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(C)c2)no1 10.1016/j.bmcl.2009.11.121
54581664 61858 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777960 61858 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142439 125389 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648470 125389 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142837 125405 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648486 125405 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
11225601 141495 0 None -3 2 Rabbit 8.4 pIC50 = 8.4 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141495 0 None -3 2 Rabbit 8.4 pIC50 = 8.4 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
46230989 198505 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 477 5 2 7 4.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL596623 198505 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 477 5 2 7 4.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
11433587 15054 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210745 15054 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23630511 144242 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 486 7 3 5 4.4 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
CHEMBL390916 144242 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 486 7 3 5 4.4 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
56835162 69221 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69221 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
11519239 185178 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486640 185178 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
60142961 125406 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648487 125406 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3038096 209185 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1 10.1021/jm950716i
16108966 83959 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221925 83959 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
46230836 197585 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 389 4 2 6 3.5 Cc1nc(-c2c(F)cccc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590153 197585 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 389 4 2 6 3.5 Cc1nc(-c2c(F)cccc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
11203826 139592 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL380117 139592 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
56594770 65397 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65397 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
24946265 186481 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491219 186481 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
42605727 197727 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 8 2 5 2.1 CCN(CC)C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL591111 197727 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 8 2 5 2.1 CCN(CC)C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
57399885 69740 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCC(C)CC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939923 69740 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCC(C)CC2)cc1 10.1016/j.bmcl.2011.11.112
49863227 15050 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210741 15050 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
46230890 199575 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 408 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL603894 199575 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 408 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
49863232 15058 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210749 15058 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23631015 92525 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 626 8 2 6 5.5 CN1CCC(N2CCC(CCNC(=O)c3nn(-c4ccccc4)c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
CHEMBL244124 92525 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 626 8 2 6 5.5 CN1CCC(N2CCC(CCNC(=O)c3nn(-c4ccccc4)c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
2818985 92765 5 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 431 3 2 2 6.0 CC(C)(C)c1ccc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cc1 10.1021/jm051292n
CHEMBL244522 92765 5 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 431 3 2 2 6.0 CC(C)(C)c1ccc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cc1 10.1021/jm051292n
44579913 183589 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL483036 183589 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
44419046 97822 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 595 10 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCc2cc(CCN3CCCCC3)ccc2C1 10.1021/jm061224g
CHEMBL274624 97822 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 595 10 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCc2cc(CCN3CCCCC3)ccc2C1 10.1021/jm061224g
659 2854 13 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2854 13 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2854 13 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
44579968 192522 0 None - 1 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 490 8 1 6 3.9 CN(Cc1ccc(-c2ncccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL522789 192522 0 None - 1 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 490 8 1 6 3.9 CN(Cc1ccc(-c2ncccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16220989 141967 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL389054 141967 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
60142568 125392 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648473 125392 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
56594373 65552 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1835762 65552 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
56594771 65449 0 None -2 2 Rabbit 6.5 pIC50 = 6.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65449 0 None -2 2 Rabbit 6.5 pIC50 = 6.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
44579652 186594 0 None -57 2 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492211 186594 0 None -57 2 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
60142963 125408 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125408 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
46230308 199901 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 5 2 4 4.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2nc3ccccc3[nH]2)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL605634 199901 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 5 2 4 4.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2nc3ccccc3[nH]2)c(F)c1 10.1016/j.bmcl.2009.11.120
46230259 198791 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 319 4 1 3 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(C)=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL598552 198791 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 319 4 1 3 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(C)=O)c(F)c1 10.1016/j.bmcl.2009.11.120
16220913 85126 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227828 85126 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44579829 186409 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490618 186409 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108967 83926 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221691 83926 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
57395451 69724 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1cccc2c1CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939766 69724 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1cccc2c1CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
57394687 69766 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 494 5 1 5 2.4 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939949 69766 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 494 5 1 5 2.4 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL3038105 209193 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N(CC(=O)N1C2CCCCC2C[C@H]1C(=O)O)Cc1ccccc1 10.1021/jm950716i
11555433 188402 0 None 2 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188402 0 None 2 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
57403174 69217 0 None -5 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69217 0 None -5 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44579829 186409 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490618 186409 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
56835162 69221 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69221 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
56594770 65397 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65397 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
11663809 173029 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173029 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
16108961 910 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 910 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 910 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142302 125380 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648461 125380 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60141039 125414 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648495 125414 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
53248885 61856 0 None -18 2 Rabbit 8.4 pIC50 = 8.4 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
CHEMBL1777958 61856 0 None -18 2 Rabbit 8.4 pIC50 = 8.4 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
54582656 61872 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777974 61872 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11635365 173989 0 None 2 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 173989 0 None 2 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
60141181 125417 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648498 125417 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
46230068 199363 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 527 4 2 4 4.4 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)N(C)NC(=O)c2cc(F)cc(C(F)(F)F)c2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL602555 199363 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 527 4 2 4 4.4 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)N(C)NC(=O)c2cc(F)cc(C(F)(F)F)c2)c(F)c1 10.1016/j.bmcl.2009.11.119
44561643 185066 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185066 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
60142566 125388 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648469 125388 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
46230938 199586 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 5 2 7 2.8 CCN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL603962 199586 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 5 2 7 2.8 CCN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
46216744 199896 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 508 6 2 7 5.7 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc2ccccc21 10.1016/j.bmcl.2009.11.120
CHEMBL605570 199896 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 508 6 2 7 5.7 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc2ccccc21 10.1016/j.bmcl.2009.11.120
60143099 125412 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648493 125412 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
57394689 69768 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 5 1 5 2.6 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939951 69768 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 5 1 5 2.6 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
60141327 125426 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
CHEMBL3648507 125426 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
57395702 69730 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 453 5 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939771 69730 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 453 5 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
44579889 186033 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 528 5 0 6 3.2 CN1CCC(N2CCN(C(=O)C3CCN(C(=O)c4nc5ccccc5n4Cc4ccccc4)CC3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL487908 186033 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 528 5 0 6 3.2 CN1CCC(N2CCN(C(=O)C3CCN(C(=O)c4nc5ccccc5n4Cc4ccccc4)CC3)CC2)CC1 10.1016/j.bmcl.2008.08.014
137640759 156540 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1756 21 21 23 -5.9 CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2 10.1021/acs.jmedchem.6b01011
CHEMBL4074308 156540 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1756 21 21 23 -5.9 CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2 10.1021/acs.jmedchem.6b01011
44579967 186440 0 None - 1 Crab-eating macaque 6.4 pIC50 = 6.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 489 8 1 5 4.5 CN(Cc1ccc(-c2ccccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490827 186440 0 None - 1 Crab-eating macaque 6.4 pIC50 = 6.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 489 8 1 5 4.5 CN(Cc1ccc(-c2ccccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44579891 191497 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 5 0 6 3.4 O=C([C@H]1CCCN1C(=O)c1nc2ccccc2n1Cc1ccccc1)N1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL520304 191497 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 5 0 6 3.4 O=C([C@H]1CCCN1C(=O)c1nc2ccccc2n1Cc1ccccc1)N1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2008.08.014
11331054 15052 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210743 15052 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
24946265 186481 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491219 186481 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108962 141188 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385740 141188 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
46911684 15062 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210753 15062 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23627523 73509 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018872 73509 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
11215189 168228 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL437509 168228 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
46230306 198522 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 345 4 0 3 3.5 COC(=O)c1c(F)cccc1-c1ccc(CN2CCCC2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL596718 198522 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 345 4 0 3 3.5 COC(=O)c1c(F)cccc1-c1ccc(CN2CCCC2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
23627583 73511 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018874 73511 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
44410254 75605 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
CHEMBL205242 75605 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
44410020 137692 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL377011 137692 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
49863236 15063 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210754 15063 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23630918 92314 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243650 92314 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
11635364 173990 0 None 4 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 173990 0 None 4 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
44410250 75602 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
CHEMBL205227 75602 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
16108968 165585 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL426165 165585 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16202227 73508 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018871 73508 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
16220915 85109 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227690 85109 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221108 85106 0 None -22 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85106 0 None -22 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
60142165 125374 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3648456 125374 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3038103 209191 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1)C1CCCC1 10.1021/jm950716i
11478613 140061 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381372 140061 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
16221229 85142 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
CHEMBL227977 85142 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
44579850 186583 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 7 0 6 3.2 CC(C)N(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492048 186583 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 7 0 6 3.2 CC(C)N(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
49863237 15064 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210755 15064 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11330286 76117 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL205981 76117 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
60142026 125371 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648453 125371 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
54583583 61843 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777880 61843 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
56594241 65546 0 None -4 2 Rabbit 6.3 pIC50 = 6.3 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65546 0 None -4 2 Rabbit 6.3 pIC50 = 6.3 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
11663606 192982 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL530554 192982 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
23630513 143446 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 542 5 4 5 4.0 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL390272 143446 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 542 5 4 5 4.0 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1 10.1021/jm051292n
11224694 92334 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243667 92334 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44579795 186362 0 None 30 2 Crab-eating macaque 8.3 pIC50 = 8.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490201 186362 0 None 30 2 Crab-eating macaque 8.3 pIC50 = 8.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
42606292 197858 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 519 6 2 3 5.0 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL592238 197858 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 519 6 2 3 5.0 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)cc1 10.1016/j.bmcl.2009.11.119
60142569 125393 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648474 125393 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
11478717 92356 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 576 5 4 5 4.6 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243679 92356 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 576 5 4 5 4.6 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
16108969 82618 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL218152 82618 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
16108969 82618 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL218152 82618 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
16108960 168693 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL441188 168693 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
60141183 125419 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
CHEMBL3648500 125419 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
11670860 185180 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486641 185180 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
42606173 197728 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 8 2 5 2.9 CC(C)N(C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1)C(C)C 10.1016/j.bmcl.2009.11.119
CHEMBL591112 197728 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 8 2 5 2.9 CC(C)N(C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1)C(C)C 10.1016/j.bmcl.2009.11.119
16108963 161418 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415849 161418 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
23627458 73506 0 None - 1 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018869 73506 0 None - 1 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
44579849 186317 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2cn[nH]c2c1 10.1016/j.bmcl.2008.08.014
CHEMBL489808 186317 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2cn[nH]c2c1 10.1016/j.bmcl.2008.08.014
11452874 151857 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL397037 151857 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44579865 186220 0 None - 1 Crab-eating macaque 7.3 pIC50 = 7.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 9 2 6 3.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CCNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489203 186220 0 None - 1 Crab-eating macaque 7.3 pIC50 = 7.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 9 2 6 3.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CCNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11238372 168474 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL439505 168474 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
44419100 82751 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 11 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL218314 82751 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 11 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
44410179 165763 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL427208 165763 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
11373520 151529 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 419 4 3 4 3.7 O=C(Nc1[nH]nc(C(=O)Nc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL396735 151529 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 419 4 3 4 3.7 O=C(Nc1[nH]nc(C(=O)Nc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
16221227 142486 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
CHEMBL389477 142486 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
16221163 85145 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL228030 85145 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
46230892 198847 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 395 4 3 7 2.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)NO)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL598868 198847 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 395 4 3 7 2.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)NO)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
44410269 165581 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL426130 165581 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
44579652 186594 0 None 57 2 Crab-eating macaque 8.2 pIC50 = 8.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492211 186594 0 None 57 2 Crab-eating macaque 8.2 pIC50 = 8.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44419045 136764 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL375229 136764 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
23630809 166806 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 451 4 3 4 2.9 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CN3CCC2CC3)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL429463 166806 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 451 4 3 4 2.9 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CN3CCC2CC3)c1Br)c1ccccc1Cl 10.1021/jm051292n
16221110 84611 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL224071 84611 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221164 161197 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL413786 161197 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
24946267 186411 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 7 1 6 2.4 CN1CCC(N2CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL490626 186411 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 7 1 6 2.4 CN1CCC(N2CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
60141184 125420 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648501 125420 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
46230307 199540 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 4 0 3 4.6 COC(=O)c1c(F)cccc1-c1ccc(CN2Cc3ccccc3C2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL603657 199540 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 4 0 3 4.6 COC(=O)c1c(F)cccc1-c1ccc(CN2Cc3ccccc3C2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
44587206 187564 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL498488 187564 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
44579945 186247 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 1 6 3.7 CN(Cc1ccc(-n2ccnc2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489389 186247 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 1 6 3.7 CN(Cc1ccc(-n2ccnc2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
23630612 91650 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(NC(=O)c2ccccc2Cl)c(Br)c1C(=O)NCCC1CCN(c2ccncc2)CC1 10.1021/jm051292n
CHEMBL241935 91650 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(NC(=O)c2ccccc2Cl)c(Br)c1C(=O)NCCC1CCN(c2ccncc2)CC1 10.1021/jm051292n
23630814 151571 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 508 5 4 5 3.3 CC(C)C(=O)Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br 10.1021/jm051292n
CHEMBL396771 151571 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 508 5 4 5 3.3 CC(C)C(=O)Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br 10.1021/jm051292n
57399671 69226 0 None 2 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69226 0 None 2 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
11444270 76366 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
CHEMBL206554 76366 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
24755613 192524 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 474 6 1 6 2.1 CN1CCC(N2CCN(C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL522798 192524 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 474 6 1 6 2.1 CN1CCC(N2CCN(C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
16221160 96821 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL268911 96821 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
57399670 69214 0 None 13 2 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69214 0 None 13 2 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
11386138 84020 0 None -8 2 Rabbit 8.1 pIC50 = 8.1 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84020 0 None -8 2 Rabbit 8.1 pIC50 = 8.1 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
16102899 83928 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
CHEMBL221695 83928 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
57390411 69731 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 497 5 2 6 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC3(OCCO3)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939772 69731 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 497 5 2 6 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC3(OCCO3)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
46230458 197540 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 460 6 2 8 4.6 CC(=O)Nc1nonc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL589899 197540 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 460 6 2 8 4.6 CC(=O)Nc1nonc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
11326315 149509 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 374 4 3 3 4.2 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
CHEMBL395055 149509 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 374 4 3 3 4.2 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
44410084 76577 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL207033 76577 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
60143098 125411 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648492 125411 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
23630614 141578 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 620 9 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1Cc1ccccc1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL388270 141578 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 620 9 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1Cc1ccccc1)c1ccccc1Cl 10.1021/jm051292n
44579944 186215 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 7 3.8 Cc1nc(-c2ccc(CN(C)C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)cc2)no1 10.1016/j.bmcl.2008.08.014
CHEMBL489192 186215 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 7 3.8 Cc1nc(-c2ccc(CN(C)C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)cc2)no1 10.1016/j.bmcl.2008.08.014
57400697 69727 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.0 CC(=O)N1CCC(NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)c2ccccc21 10.1016/j.bmcl.2011.11.112
CHEMBL1939769 69727 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.0 CC(=O)N1CCC(NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)c2ccccc21 10.1016/j.bmcl.2011.11.112
44410316 140332 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381964 140332 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
11691896 186123 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488512 186123 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44580046 183666 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2nc[nH]c2c1 10.1016/j.bmcl.2008.08.014
CHEMBL483653 183666 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2nc[nH]c2c1 10.1016/j.bmcl.2008.08.014
60142025 125370 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648452 125370 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
57403174 69217 0 None 5 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69217 0 None 5 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
49863235 15061 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210752 15061 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11421944 85120 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227778 85120 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
11555599 173028 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL453338 173028 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11526655 185985 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL487823 185985 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57398013 69218 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cc(Cl)ccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934257 69218 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cc(Cl)ccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
57402467 69723 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939765 69723 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
23627520 73507 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018870 73507 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
44410273 76362 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL206541 76362 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
11259614 92833 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 455 6 3 4 2.7 CC[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N(C)C 10.1021/jm051292n
CHEMBL244935 92833 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 455 6 3 4 2.7 CC[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N(C)C 10.1021/jm051292n
60142168 125377 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648459 125377 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
56951319 69744 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 392 5 3 5 0.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939927 69744 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 392 5 3 5 0.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNCC2)cc1 10.1016/j.bmcl.2011.11.112
57395449 69720 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 413 6 2 4 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H](C)c2ccccc2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939762 69720 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 413 6 2 4 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H](C)c2ccccc2)cc1 10.1016/j.bmcl.2011.11.112
11584184 172543 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL452057 172543 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
46230310 198521 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 569 8 2 10 5.5 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc(C)c2C)on1 10.1016/j.bmcl.2009.11.120
CHEMBL596717 198521 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 569 8 2 10 5.5 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc(C)c2C)on1 10.1016/j.bmcl.2009.11.120
11555433 188402 0 None -2 2 Rabbit 7.1 pIC50 = 7.1 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188402 0 None -2 2 Rabbit 7.1 pIC50 = 7.1 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
9804704 92832 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 467 6 3 4 3.5 CN1CCC(CCNC(=O)c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)CC1 10.1021/jm051292n
CHEMBL244934 92832 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 467 6 3 4 3.5 CN1CCC(CCNC(=O)c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)CC1 10.1021/jm051292n
11467345 161402 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415629 161402 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
49863228 15051 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
CHEMBL1210742 15051 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
44579915 183617 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL483241 183617 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
16102920 82797 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218553 82797 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
23630512 92123 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 466 7 3 5 4.1 Cc1c(C(=O)NCCC2CCN(c3ccncc3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243208 92123 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 466 7 3 5 4.1 Cc1c(C(=O)NCCC2CCN(c3ccncc3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
16221283 85107 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227655 85107 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
16221109 143515 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL390311 143515 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
11387915 15053 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210744 15053 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
16221055 142216 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389249 142216 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
11685446 186122 0 None 14 2 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186122 0 None 14 2 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
57395450 69721 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 425 5 2 4 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939763 69721 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 425 5 2 4 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
44410026 76443 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206901 76443 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
60142833 125401 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648482 125401 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
57400937 69729 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 454 5 3 5 1.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CC(=O)Nc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939770 69729 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 454 5 3 5 1.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CC(=O)Nc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
16221162 143791 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL390540 143791 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44410368 76408 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206801 76408 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
24946437 186192 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 7 1 6 2.9 O=C(NCCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL488983 186192 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 7 1 6 2.9 O=C(NCCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11605512 173031 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
CHEMBL453340 173031 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
57401425 69220 0 None 1 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69220 0 None 1 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
57399670 69214 0 None -13 2 Rabbit 7.0 pIC50 = 7.0 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69214 0 None -13 2 Rabbit 7.0 pIC50 = 7.0 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
54586518 61861 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777963 61861 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
642 2276 17 None 2 2 Human 6.0 pIC50 = 6 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b01011
CHEMBL384721 2276 17 None 2 2 Human 6.0 pIC50 = 6 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b01011
57394682 69739 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 391 5 2 4 1.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939922 69739 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 391 5 2 4 1.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2)cc1 10.1016/j.bmcl.2011.11.112
44354176 96307 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 10 10 0.6 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL264517 96307 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 10 10 0.6 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354059 116558 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 34 11 10 1.8 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
CHEMBL339159 116558 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 34 11 10 1.8 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
44354039 114717 0 None - 0 Rat 6.0 pKd = 6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 883 27 9 10 1.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL334538 114717 0 None - 0 Rat 6.0 pKd = 6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 883 27 9 10 1.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354174 141027 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1081 35 14 12 -1.3 NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
CHEMBL384846 141027 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1081 35 14 12 -1.3 NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
CHEMBL133560 206978 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCC1 10.1021/jm980495r
CHEMBL339389 209875 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
56668285 62988 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1145 26 13 15 -1.1 C=C([C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)CC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL1793829 62988 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1145 26 13 15 -1.1 C=C([C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)CC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL2370699 208170 4 None - 0 Rat 7.7 pKd = 7.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
44354162 24199 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 840 22 10 10 -1.7 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL134135 24199 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 840 22 10 10 -1.7 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354032 155206 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1037 26 12 12 -1.4 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCC(=O)NC1(C(=O)NCCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL405644 155206 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1037 26 12 12 -1.4 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCC(=O)NC1(C(=O)NCCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
44354038 19655 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 9 10 1.5 CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL130222 19655 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 9 10 1.5 CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354033 96596 0 None - 0 Rat 5.6 pKd = 5.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1009 24 12 12 -2.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCC(=O)NC1(C(=O)NCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL266975 96596 0 None - 0 Rat 5.6 pKd = 5.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1009 24 12 12 -2.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCC(=O)NC1(C(=O)NCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL131647 206950 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCCC1 10.1021/jm980495r
16108961 910 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 910 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 910 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
44354214 115009 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 869 24 10 10 -1.0 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL335247 115009 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 869 24 10 10 -1.0 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354175 96460 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1025 35 12 12 0.8 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@@H]1C(=O)O)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL265814 96460 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1025 35 12 12 0.8 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@@H]1C(=O)O)C1Cc2ccccc2C1 10.1021/jm980495r
44354187 116300 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 29 11 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)O)C[C@H]2CCCC[C@H]21)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL337833 116300 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 29 11 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)O)C[C@H]2CCCC[C@H]21)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL410363 211069 17 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
CHEMBL133164 206971 0 None - 0 Rat 5.2 pKd = 5.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCCCC1 10.1021/jm980495r
CHEMBL218454 207652 0 None - 0 Rat 5.2 pKd = 5.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCC(=O)NC1(C(=O)NCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL2370700 208171 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C1Cc2ccccc2C1)C1Cc2ccccc2C1 10.1021/jm980495r
44354179 165042 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 911 27 10 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL424272 165042 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 911 27 10 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354239 141069 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1011 33 11 12 0.9 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL385081 141069 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1011 33 11 12 0.9 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
11620871 165482 0 None - 0 Human 10.4 pKi = 10.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1021/jm200371q
CHEMBL425588 165482 0 None - 0 Human 10.4 pKi = 10.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1021/jm200371q
53248885 61856 0 None 18 2 Human 10.0 pKi = 10 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
CHEMBL1777958 61856 0 None 18 2 Human 10.0 pKi = 10 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
11342704 61854 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777956 61854 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11215677 61855 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777957 61855 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188125 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL504531 188125 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54582655 61867 0 None - 1 Human 10.0 pKi = 10.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777969 61867 0 None - 1 Human 10.0 pKi = 10.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
25195622 61853 0 None - 1 Human 9.9 pKi = 9.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
CHEMBL1777955 61853 0 None - 1 Human 9.9 pKi = 9.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
11215488 61852 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777954 61852 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
53248885 61856 0 None 18 2 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777958 61856 0 None 18 2 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54580628 61842 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777879 61842 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54583617 61866 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777968 61866 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581634 61847 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777884 61847 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54586519 61875 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777977 61875 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11341479 61876 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777978 61876 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594769 65395 0 None 6 2 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65395 0 None 6 2 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
11214819 61848 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777885 61848 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11387387 61865 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777967 61865 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
16221282 85112 0 None 13 2 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL227713 85112 0 None 13 2 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11168954 61845 0 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777882 61845 0 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11342350 61850 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777887 61850 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587552 61864 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777966 61864 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54581667 61873 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777975 61873 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581635 61849 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777886 61849 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56589598 65451 0 None 7 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65451 0 None 7 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
54772237 65452 0 None 6 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65452 0 None 6 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
54587514 61846 0 None - 1 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777883 61846 0 None - 1 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
56594642 65392 0 None 21 2 Human 9.1 pKi = 9.1 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65392 0 None 21 2 Human 9.1 pKi = 9.1 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
9894973 101288 0 None - 0 Rat 9.0 pKi = 9.0 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
CHEMBL299832 101288 0 None - 0 Rat 9.0 pKi = 9.0 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
54582656 61872 0 None - 1 Human 9.0 pKi = 9.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777974 61872 0 None - 1 Human 9.0 pKi = 9.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11364466 61844 0 None - 1 Human 8.9 pKi = 8.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777881 61844 0 None - 1 Human 8.9 pKi = 8.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587553 61877 0 None - 1 Human 8.8 pKi = 8.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777979 61877 0 None - 1 Human 8.8 pKi = 8.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594640 65390 0 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 524 5 1 5 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834614 65390 0 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 524 5 1 5 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)cccc12 10.1021/jm200808v
54581666 61868 0 None - 1 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777970 61868 0 None - 1 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
10388673 71059 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
CHEMBL195883 71059 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
16221282 85112 0 None - 2 Rat 6.9 pKi = 6.9 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85112 0 None - 2 Rat 6.9 pKi = 6.9 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
16221108 85106 0 None - 2 Rat 6.8 pKi = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85106 0 None - 2 Rat 6.8 pKi = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
56594371 65550 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2csc3ccccc3c2=O)c1 10.1021/jm200808v
CHEMBL1835760 65550 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2csc3ccccc3c2=O)c1 10.1021/jm200808v
16102897 86811 13 None - 1 Rat 5.8 pKi = 5.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
CHEMBL232943 86811 13 None - 1 Rat 5.8 pKi = 5.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
56672397 65542 0 None - 1 Human 5.8 pKi = 5.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
CHEMBL1835752 65542 0 None - 1 Human 5.8 pKi = 5.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
54580655 61860 0 None - 1 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777962 61860 0 None - 1 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594372 65551 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2csc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835761 65551 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2csc3ccccc3c2=O)cc1 10.1021/jm200808v
56594242 65547 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835757 65547 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1021/jm200808v
44569935 168925 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL443207 168925 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
56594643 65393 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cc(Cl)ccc12 10.1021/jm200808v
CHEMBL1834617 65393 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cc(Cl)ccc12 10.1021/jm200808v
11284304 61870 0 None - 1 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777972 61870 0 None - 1 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594772 65450 0 None 15 2 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65450 0 None 15 2 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
16221056 85134 0 None - 2 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85134 0 None - 2 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
56594507 65557 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 534 6 1 5 6.3 CC(C)c1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835768 65557 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 534 6 1 5 6.3 CC(C)c1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
11284458 140058 2 None - 1 Human 7.6 pKi = 7.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
CHEMBL381366 140058 2 None - 1 Human 7.6 pKi = 7.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
44569936 172614 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL452238 172614 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
56594506 65556 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 520 6 1 5 5.7 CCc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835767 65556 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 520 6 1 5 5.7 CCc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
56658544 65543 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1)c1ccccc1 10.1021/jm200808v
CHEMBL1835753 65543 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1)c1ccccc1 10.1021/jm200808v
11272685 61869 0 None - 1 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777971 61869 0 None - 1 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594770 65397 0 None 7 2 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65397 0 None 7 2 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
56594641 65391 0 None - 0 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 5 5.8 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834615 65391 0 None - 0 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 5 5.8 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
54587550 61857 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777959 61857 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56679097 65545 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1)c1ccccc1 10.1021/jm200808v
CHEMBL1835755 65545 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1)c1ccccc1 10.1021/jm200808v
56594243 65548 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 505 5 1 4 6.0 Cn1cc(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc21 10.1021/jm200808v
CHEMBL1835758 65548 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 505 5 1 4 6.0 Cn1cc(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc21 10.1021/jm200808v
56594374 65553 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835763 65553 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
11495796 73188 0 None - 0 Human 5.5 pKi = 5.5 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
CHEMBL201717 73188 0 None - 0 Human 5.5 pKi = 5.5 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
25181410 171648 1 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL447392 171648 1 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
11635365 173989 0 None 2 2 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
CHEMBL455642 173989 0 None 2 2 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
54585540 61874 0 None - 1 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777976 61874 0 None - 1 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594768 65394 0 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccc(Cl)cc12 10.1021/jm200808v
CHEMBL1834618 65394 0 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccc(Cl)cc12 10.1021/jm200808v
56594639 65389 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 568 6 1 5 6.8 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(-c3ccccc3)c3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1834613 65389 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 568 6 1 5 6.8 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(-c3ccccc3)c3ccccc3c2=O)cc1 10.1021/jm200808v
54586518 61861 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777963 61861 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44569938 188312 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL507546 188312 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
25181411 188704 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL512111 188704 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
54584600 61863 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777965 61863 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581664 61858 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777960 61858 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594505 65555 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2ncc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835766 65555 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2ncc3ccccc3c2=O)cc1 10.1021/jm200808v
54583583 61843 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777880 61843 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587551 61859 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777961 61859 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56668920 65544 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccccc1)c1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1 10.1021/jm200808v
CHEMBL1835754 65544 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccccc1)c1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1 10.1021/jm200808v
54585539 61871 0 None - 1 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777973 61871 0 None - 1 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594504 65554 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2cnc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835765 65554 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2cnc3ccccc3c2=O)cc1 10.1021/jm200808v
11546560 73588 0 None - 0 Human 7.2 pKi = 7.2 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm1013693
CHEMBL202089 73588 0 None - 0 Human 7.2 pKi = 7.2 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm1013693
56594373 65552 0 None - 1 Human 5.2 pKi = 5.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835762 65552 0 None - 1 Human 5.2 pKi = 5.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1021/jm200808v
56594241 65546 0 None 4 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1021/jm200808v
CHEMBL1835756 65546 0 None 4 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1021/jm200808v
56594771 65449 0 None 2 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65449 0 None 2 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
54581665 61862 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2(C)CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777964 61862 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2(C)CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44411297 77008 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1021/jm200371q
CHEMBL208538 77008 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1021/jm200371q
56594508 65558 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 560 5 1 5 6.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(C(F)(F)F)c3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835769 65558 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 560 5 1 5 6.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(C(F)(F)F)c3ccccc3c2=O)cc1 10.1021/jm200808v
653 559 0 None -199 3 Mouse 6.1 pA2 = 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
123884 2274 13 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
641 2274 13 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
CHEMBL80472 2274 13 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
642 2276 17 None -2 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
CHEMBL384721 2276 17 None -2 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
661 3227 0 None -31 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
663 1350 0 None - 1 Mouse 7.2 pA2 = 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
653 559 0 None -5 3 Human 7.7 pA2 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
661 3227 0 None 31 2 Human 8.5 pA2 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8901831
101865250 3228 0 None - 1 Human 8.6 pA2 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None NCCC[C@@H](C(=O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)Cc1ccc2c(c1)cccc2)CO)(Cc1ccccc1)C)CCCN=C(N)N)NC(=O)C 24361511
3906 3228 0 None - 1 Human 8.6 pA2 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None NCCC[C@@H](C(=O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)Cc1ccc2c(c1)cccc2)CO)(Cc1ccccc1)C)CCCN=C(N)N)NC(=O)C 24361511
654 560 0 None - 1 Human 9.2 pA2 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
123884 2274 13 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
641 2274 13 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
CHEMBL80472 2274 13 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
642 2276 17 None 2 2 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
CHEMBL384721 2276 17 None 2 2 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
10254 2775 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 26565554
3035449 2480 0 None -39 3 Human 7.1 pIC50 None 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
638 2480 0 None -39 3 Human 7.1 pIC50 None 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
16108961 910 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
664 910 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
CHEMBL415848 910 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
16108961 910 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
664 910 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
CHEMBL415848 910 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
665 959 2 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 959 2 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 959 2 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
122227 1351 27 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
3825 1351 27 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
644 1351 27 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
CHEMBL264100 1351 27 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
44579694 192541 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 7 3 5 3.6 Cc1c(C(=O)NCCC2CCN(C3CCN(C)CC3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1016/j.bmcl.2008.08.014
CHEMBL522947 192541 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 7 3 5 3.6 Cc1c(C(=O)NCCC2CCN(C3CCN(C)CC3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1016/j.bmcl.2008.08.014
10031511 16765 0 None 1 2 Human 8.7 pIC50 = 8.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16765 0 None 1 2 Human 8.7 pIC50 = 8.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
11204003 76868 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
CHEMBL207947 76868 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
44410020 137692 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL377011 137692 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
44410316 140332 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381964 140332 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
44410269 165581 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL426130 165581 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11215189 168228 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL437509 168228 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11444270 76366 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
CHEMBL206554 76366 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
11444165 140348 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
CHEMBL381979 140348 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
11512379 165452 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
CHEMBL425416 165452 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
44410368 76408 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206801 76408 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11203826 139592 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL380117 139592 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
44410026 76443 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206901 76443 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
665 959 2 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 959 2 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 959 2 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
10187347 192757 0 None - 1 Human 6.8 pIC50 = 6.8 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL52498 192757 0 None - 1 Human 6.8 pIC50 = 6.8 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44410143 76983 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
CHEMBL208386 76983 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
44410084 76577 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL207033 76577 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
10031511 16765 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16765 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
10031511 16765 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16765 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
11478613 140061 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381372 140061 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44410250 75602 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
CHEMBL205227 75602 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
10875606 62744 0 None - 1 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1788318 62744 0 None - 1 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11284458 140058 2 None - 1 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381366 140058 2 None - 1 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11017305 60008 0 None - 1 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 60008 0 None - 1 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11071992 60006 0 None 3 2 Human 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 60006 0 None 3 2 Human 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11039234 60009 0 None -1 2 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 60009 0 None -1 2 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
44455075 94908 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL256671 94908 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
44410186 76864 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL207945 76864 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
16726096 154729 7 None 2 4 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154729 7 None 2 4 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
11050306 60007 0 None 1 2 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 60007 0 None 1 2 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
44455035 95280 0 None - 1 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL258324 95280 0 None - 1 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
44455108 154605 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL402114 154605 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11330286 76117 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL205981 76117 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
44410273 76362 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL206541 76362 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
11238372 168474 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL439505 168474 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
11071992 60006 0 None -3 2 Rat 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 60006 0 None -3 2 Rat 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11307733 74547 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL203174 74547 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44455073 95142 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL257729 95142 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
44455038 95281 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL258326 95281 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
44410254 75605 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
CHEMBL205242 75605 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
44410328 75652 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL205501 75652 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11284303 66010 0 None -2 2 Human 5.2 pIC50 = 5.2 Binding
Inhibition of Bradykinin receptor B1 expressed in HEK293 cellsInhibition of Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL185068 66010 0 None -2 2 Human 5.2 pIC50 = 5.2 Binding
Inhibition of Bradykinin receptor B1 expressed in HEK293 cellsInhibition of Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
11039234 60009 0 None 1 2 Human 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 60009 0 None 1 2 Human 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
44410179 165763 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL427208 165763 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
11050306 60007 0 None -1 2 Rat 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 60007 0 None -1 2 Rat 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
11214998 76202 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206247 76202 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44410313 75449 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL204847 75449 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11017305 60008 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 60008 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11420875 76984 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL208387 76984 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11757682 121526 0 None 2 4 Human 10.8 pKd = 10.8 Binding
Equilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determinedEquilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determined
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121526 0 None 2 4 Human 10.8 pKd = 10.8 Binding
Equilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determinedEquilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determined
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11444808 53671 0 None - 1 Human 11.0 pKi = 11 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 601 8 3 6 4.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL160547 53671 0 None - 1 Human 11.0 pKi = 11 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 601 8 3 6 4.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11757682 121526 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121526 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11757682 121526 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121526 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11319515 66396 0 None - 1 Human 10.7 pKi = 10.7 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 615 8 2 6 4.5 CN1CCN=C1c1ccc(CCNC(=O)C[C@@H]2C(=O)Nc3ccc(Cl)cc3N2S(=O)(=O)c2ccc3ccccc3c2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185693 66396 0 None - 1 Human 10.7 pKi = 10.7 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 615 8 2 6 4.5 CN1CCN=C1c1ccc(CCNC(=O)C[C@@H]2C(=O)Nc3ccc(Cl)cc3N2S(=O)(=O)c2ccc3ccccc3c2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL3085458 209242 3 None 398 2 Human 10.6 pKi = 10.6 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL3085458 209242 3 None 398 2 Human 10.6 pKi = 10.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990962k
665 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
9916412 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
CHEMBL189123 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
665 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
665 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
9916412 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
CHEMBL189123 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
665 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
9916412 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
CHEMBL189123 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
665 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 959 2 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
90662943 106102 0 None 1778 2 Human 10.5 pKi = 10.5 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1192 30 14 17 -4.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL3142391 106102 0 None 1778 2 Human 10.5 pKi = 10.5 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1192 30 14 17 -4.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
665 959 2 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 959 2 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 959 2 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
11620871 165482 0 None - 1 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165482 0 None - 1 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11570120 69713 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939755 69713 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
665 959 2 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 959 2 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 959 2 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
11757682 121526 0 None -2 4 Rabbit 10.3 pKi = 10.3 Binding
Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121526 0 None -2 4 Rabbit 10.3 pKi = 10.3 Binding
Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11620871 165482 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165482 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11365433 66401 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 599 8 3 5 5.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185727 66401 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 599 8 3 5 5.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
11180561 66418 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 565 8 3 5 4.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185811 66418 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 565 8 3 5 4.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
11620871 165482 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165482 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44587187 188125 0 None - 1 Human 10.0 pKi = 10 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL504531 188125 0 None - 1 Human 10.0 pKi = 10 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
10288906 135875 0 None - 1 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373530 135875 0 None - 1 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44587186 172149 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL450541 172149 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
53248885 61856 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777958 61856 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
24970287 187839 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL502140 187839 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
57397292 69716 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939758 69716 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16041612 172399 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172399 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455519 97419 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 8 2 3 5.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL272278 97419 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 8 2 3 5.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
11387624 159029 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 576 9 2 6 5.6 C[C@@H](NC(=O)C1(NC(=O)c2cc(Cl)no2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL410281 159029 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 576 9 2 6 5.6 C[C@@H](NC(=O)C1(NC(=O)c2cc(Cl)no2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
11352746 77173 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.6 CCN1CCC(N2CCN(C(=O)COCCN(C)S(=O)(=O)c3c(C)cc(OC)cc3C)CC2)CC1 10.1021/jm2016057
CHEMBL2087422 77173 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.6 CCN1CCC(N2CCN(C(=O)COCCN(C)S(=O)(=O)c3c(C)cc(OC)cc3C)CC2)CC1 10.1021/jm2016057
44316161 160969 0 None 1 2 Human 9.7 pKi = 9.7 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1043 25 12 16 -4.0 NCCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O 10.1021/jm990961s
CHEMBL412824 160969 0 None 1 2 Human 9.7 pKi = 9.7 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1043 25 12 16 -4.0 NCCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O 10.1021/jm990961s
122227 1351 27 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
3825 1351 27 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
644 1351 27 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
CHEMBL264100 1351 27 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
44587189 171875 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL447870 171875 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16108969 82618 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL218152 82618 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
44587189 171875 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
CHEMBL447870 171875 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
16108969 82618 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL218152 82618 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
24895452 185717 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487445 185717 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895452 185717 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
CHEMBL487445 185717 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
11848206 16916 45 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 500 3 0 4 5.4 O=C(c1cccc(N2Cc3cccc(Cl)c3C2=O)c1)N1CCC2(CC1)CCN(c1ccncc1)CC2 10.1021/jm1000776
CHEMBL1254945 16916 45 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 500 3 0 4 5.4 O=C(c1cccc(N2Cc3cccc(Cl)c3C2=O)c1)N1CCC2(CC1)CCN(c1ccncc1)CC2 10.1021/jm1000776
11953367 16890 12 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
CHEMBL1254771 16890 12 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
44455075 94908 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL256671 94908 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11953367 16890 12 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
CHEMBL1254771 16890 12 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
44580744 187306 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 480 5 2 8 2.9 C[C@@H](NC(=O)C1(O)CCSC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL496530 187306 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 480 5 2 8 2.9 C[C@@H](NC(=O)C1(O)CCSC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44430696 87524 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234096 87524 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
23628223 87507 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL233968 87507 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455268 94765 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL255997 94765 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44455087 155026 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 549 8 2 7 4.7 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(OC)no3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404370 155026 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 549 8 2 7 4.7 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(OC)no3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
16221282 85112 0 None 316 2 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85112 0 None 316 2 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
10173772 161322 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL414962 161322 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
11283865 77185 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 523 10 0 6 3.3 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087434 77185 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 523 10 0 6 3.3 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
11442712 84802 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84802 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
24884552 183713 1 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 7 4.0 C[C@@H](NC(=O)C1(O)CCC(F)(F)CC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484055 183713 1 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 7 4.0 C[C@@H](NC(=O)C1(O)CCC(F)(F)CC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44455004 97237 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 7 3.9 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1Cl 10.1016/j.bmcl.2007.11.050
CHEMBL271283 97237 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 7 3.9 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1Cl 10.1016/j.bmcl.2007.11.050
16102897 86811 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232943 86811 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
44587184 169587 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL444431 169587 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16102897 86811 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86811 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
16102897 86811 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
CHEMBL232943 86811 13 None 7 3 Human 9.4 pKi = 9.4 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
23628223 87507 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL233968 87507 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
57390218 69718 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939760 69718 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
44580743 192044 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 462 5 2 7 3.4 C[C@@H](NC(=O)C1(O)CCCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL521735 192044 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 462 5 2 7 3.4 C[C@@H](NC(=O)C1(O)CCCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
11757682 121526 0 None -28 4 Dog 9.3 pKi = 9.3 Binding
Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121526 0 None -28 4 Dog 9.3 pKi = 9.3 Binding
Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11284564 155050 1 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 572 10 2 7 5.0 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
CHEMBL404484 155050 1 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 572 10 2 7 5.0 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
11363856 84114 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84114 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
11225601 141495 0 None 6 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141495 0 None 6 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
16726096 154729 7 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2008.07.126
CHEMBL402831 154729 7 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2008.07.126
10217706 82812 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
CHEMBL218605 82812 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
16102883 165313 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL424919 165313 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
57400696 69717 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939759 69717 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
10151875 136455 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL374580 136455 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44455035 95280 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL258324 95280 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
10031511 16765 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16765 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
10031511 16765 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16765 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
9894973 101288 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
CHEMBL299832 101288 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
57383007 126688 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657638 126688 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
16747694 87525 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234097 87525 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
24895550 173353 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173353 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455090 97016 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 8 2 6 4.7 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL270173 97016 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 8 2 6 4.7 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
10239095 83501 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL220657 83501 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
44455038 95281 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL258326 95281 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
16726096 154729 7 None 2 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154729 7 None 2 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
16102898 165650 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(Cl)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL426561 165650 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(Cl)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
44580049 184005 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 476 5 2 8 2.5 C[C@@H](NC(=O)C1(O)CCC(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484881 184005 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 476 5 2 8 2.5 C[C@@H](NC(=O)C1(O)CCC(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44593650 184008 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484882 184008 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44432186 86271 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 6 2 4 4.5 COC(=O)c1c(F)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL231734 86271 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 6 2 4 4.5 COC(=O)c1c(F)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
10196170 136032 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373803 136032 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11442712 84802 0 None -1 3 Rabbit 9.2 pKi = 9.2 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84802 0 None -1 3 Rabbit 9.2 pKi = 9.2 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44580048 183561 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 9 1.6 C[C@@H](NC(=O)C1(O)CCS(=O)(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL482829 183561 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 9 1.6 C[C@@H](NC(=O)C1(O)CCS(=O)(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
16041612 172399 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172399 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
24893993 173352 5 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454085 173352 5 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm800199h
44587183 172655 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL452331 172655 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16108961 910 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
664 910 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
CHEMBL415848 910 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
11387915 15053 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210744 15053 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
24893993 173352 5 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm1000776
CHEMBL454085 173352 5 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm1000776
11488817 77184 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 495 9 0 6 2.5 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087433 77184 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 495 9 0 6 2.5 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
11386138 84020 0 None 1 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84020 0 None 1 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
11477390 84737 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
CHEMBL225218 84737 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
44411294 76980 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 450 7 2 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208371 76980 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 450 7 2 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)c(F)c1 10.1016/j.bmcl.2006.01.112
16726109 146361 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 487 6 2 5 3.7 COC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL392551 146361 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 487 6 2 5 3.7 COC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16108961 910 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 910 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 910 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
44455073 95142 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL257729 95142 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
57382836 126670 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 501 7 2 7 3.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)COC2)c(F)c1 nan
CHEMBL3657620 126670 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 501 7 2 7 3.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)COC2)c(F)c1 nan
68869647 77174 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 10 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C4CC4)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087423 77174 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 10 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C4CC4)CC3)CC2)c(C)c1 10.1021/jm2016057
11167607 136821 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL375288 136821 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44580742 187305 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 506 6 3 7 3.7 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(CO)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL496529 187305 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 506 6 3 7 3.7 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(CO)n2)cc1F 10.1016/j.bmcl.2008.07.126
44418930 82903 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219083 82903 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
16102896 83125 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 7 2 4 4.1 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL220371 83125 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 7 2 4 4.1 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
11281533 64746 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 64746 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11620871 165482 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165482 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411452 76565 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207022 76565 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
665 959 2 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 959 2 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 959 2 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL2369827 207949 0 None - 1 Human 9.1 pKi = 9.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCCN)C(=O)O 10.1021/jm990961s
44455574 155093 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 472 7 2 3 4.9 CCOc1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404683 155093 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 472 7 2 3 4.9 CCOc1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455875 155097 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 3 5.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OC(CF)CF)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL404705 155097 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 3 5.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OC(CF)CF)cc1F 10.1016/j.bmcl.2007.11.057
10031511 16765 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16765 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
10031511 16765 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16765 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
16102918 83857 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 416 6 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
CHEMBL221288 83857 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 416 6 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
44580209 183688 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 478 5 2 8 2.6 C[C@@H](NC(=O)C1(O)CCOCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL483858 183688 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 478 5 2 8 2.6 C[C@@H](NC(=O)C1(O)CCOCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
57382837 126671 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 515 7 2 7 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(C)no3)COC2)c(F)c1 nan
CHEMBL3657621 126671 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 515 7 2 7 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(C)no3)COC2)c(F)c1 nan
57382923 126680 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657630 126680 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
57382925 126682 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccnnc4)COC3)c(F)c2)no1 nan
CHEMBL3657632 126682 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccnnc4)COC3)c(F)c2)no1 nan
11281533 64746 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 64746 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11320189 65154 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 746 17 1 8 4.5 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c(C(=O)N3CCOCC3)c2)CC1 10.1021/jm049747g
CHEMBL183048 65154 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 746 17 1 8 4.5 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c(C(=O)N3CCOCC3)c2)CC1 10.1021/jm049747g
70685471 73503 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.1 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018866 73503 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.1 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
44593650 184008 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484882 184008 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
11786597 67136 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 583 8 2 6 4.4 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2ccnc2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL189245 67136 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 583 8 2 6 4.4 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2ccnc2)cc1 10.1016/j.bmcl.2004.09.074
57382750 126663 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncnc4)COC3)c(F)c2)no1 nan
CHEMBL3657613 126663 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncnc4)COC3)c(F)c2)no1 nan
57382839 126673 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 10 3.2 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657623 126673 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 10 3.2 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
57383057 126697 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 599 10 2 8 4.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
CHEMBL3657647 126697 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 599 10 2 8 4.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
57383099 126701 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 10 2.7 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657651 126701 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 10 2.7 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
44432215 86534 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 528 6 2 6 3.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL232354 86534 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 528 6 2 6 3.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
11444668 155004 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 586 11 2 7 5.4 CCOc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
CHEMBL404280 155004 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 586 11 2 7 5.4 CCOc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
11386138 84020 0 None -1 3 Rabbit 9.0 pKi = 9.0 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84020 0 None -1 3 Rabbit 9.0 pKi = 9.0 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44587185 188351 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL508043 188351 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11306090 84723 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 6 2 4 6.6 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1 10.1021/jm049394l
CHEMBL225006 84723 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 6 2 4 6.6 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1 10.1021/jm049394l
57382924 126681 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 8 4.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657631 126681 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 8 4.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
57383053 126693 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 11 2.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657643 126693 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 11 2.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
44432221 86812 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 501 7 2 5 4.1 CCOC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232945 86812 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 501 7 2 5 4.1 CCOC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16202227 73508 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018871 73508 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
24895253 186140 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 538 10 3 5 4.7 O=C(NCCCN1CCCC(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL488662 186140 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 538 10 3 5 4.7 O=C(NCCCN1CCCC(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
44455364 154503 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccon2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL401619 154503 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccon2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587181 188092 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL503847 188092 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
44421279 84732 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225133 84732 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
57398978 69715 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939757 69715 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57382967 126687 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 554 7 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnc4)COC3)c(F)c2)no1 nan
CHEMBL3657637 126687 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 554 7 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnc4)COC3)c(F)c2)no1 nan
11281533 64746 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 64746 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
24895550 173353 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173353 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455549 155015 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 7 2 3 5.6 CCOc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404328 155015 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 7 2 3 5.6 CCOc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
11215913 136016 0 None 26915 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL373654 136016 0 None 26915 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
11017305 60008 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 60008 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
16102920 82797 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218553 82797 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11050306 60007 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 60007 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
10128412 86970 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1nc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
CHEMBL233351 86970 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1nc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
57382838 126672 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 10 3.4 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657622 126672 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 10 3.4 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
57382965 126685 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 7 3 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncc(N)c4)COC3)c(F)c2)no1 nan
CHEMBL3657635 126685 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 7 3 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncc(N)c4)COC3)c(F)c2)no1 nan
57383098 126700 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 8 2 10 2.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657650 126700 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 8 2 10 2.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
44411062 76968 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 9 1 6 5.0 CCCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208320 76968 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 9 1 6 5.0 CCCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
11307467 154684 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 6 5.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
CHEMBL402630 154684 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 6 5.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
16102899 83928 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
CHEMBL221695 83928 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
44432181 87328 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)ccc2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL233764 87328 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)ccc2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
16102907 161195 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL413775 161195 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10233880 77101 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 714 17 3 6 4.8 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN2CCCC2)Cc2ccc(C(=N)N)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087031 77101 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 714 17 3 6 4.8 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN2CCCC2)Cc2ccc(C(=N)N)cc2)c1Cl 10.1021/jm2016057
44411358 75179 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 1 6 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL204356 75179 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 1 6 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411364 77384 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 5.0 CCC(C)N1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208991 77384 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 5.0 CCC(C)N1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
44411101 140346 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL381974 140346 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102907 161195 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL413775 161195 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
44455089 96975 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 507 7 2 4 5.0 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL269963 96975 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 507 7 2 4 5.0 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455366 154798 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 543 8 2 4 5.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL403202 154798 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 543 8 2 4 5.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44561786 172094 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL449789 172094 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44432212 144636 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 6 4.4 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL391227 144636 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 6 4.4 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
57382794 126665 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 512 7 2 7 3.1 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)COC2)c(F)c1 nan
CHEMBL3657615 126665 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 512 7 2 7 3.1 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)COC2)c(F)c1 nan
57382877 126674 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 575 7 2 10 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4snnc4C)COC3)c(F)c2)no1 nan
CHEMBL3657624 126674 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 575 7 2 10 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4snnc4C)COC3)c(F)c2)no1 nan
57382881 126678 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 10 2.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657628 126678 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 10 2.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
16108960 168693 0 None 30902 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL441188 168693 0 None 30902 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
10196170 136032 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373803 136032 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11340940 77172 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087421 77172 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
44580047 191993 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 496 5 2 8 1.9 C[C@@H](NC(=O)C1(O)CC[S+]([O-])C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL521454 191993 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 496 5 2 8 1.9 C[C@@H](NC(=O)C1(O)CC[S+]([O-])C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
57395448 69714 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939756 69714 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57382922 126679 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 6 2 7 3.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
CHEMBL3657629 126679 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 6 2 7 3.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
44411054 76722 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 8 1 6 4.6 CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207378 76722 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 8 1 6 4.6 CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
44411093 139801 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380679 139801 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
23627521 73510 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018873 73510 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
44587182 188105 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL504119 188105 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11663809 173029 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173029 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
44432222 86813 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 535 7 2 5 4.8 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232946 86813 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 535 7 2 5 4.8 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
11620238 72691 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 497 7 2 5 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncc(C(F)(F)F)c3)CC2)cc1 10.1021/jm0511280
CHEMBL201041 72691 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 497 7 2 5 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncc(C(F)(F)F)c3)CC2)cc1 10.1021/jm0511280
44455853 168150 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 560 7 2 3 6.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL436854 168150 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 560 7 2 3 6.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587188 192768 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
CHEMBL525092 192768 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
71454501 78599 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 5.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113087 78599 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 5.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
44432198 146776 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 2 4 5.4 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL392903 146776 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 2 4 5.4 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16726096 154729 7 None 2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to monkey bradykinin B1 receptor expressed in CHO cellsBinding affinity to monkey bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154729 7 None 2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to monkey bradykinin B1 receptor expressed in CHO cellsBinding affinity to monkey bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
11398971 94960 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 570 10 2 6 5.5 CCc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
CHEMBL256903 94960 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 570 10 2 6 5.5 CCc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
16102923 84200 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 3 5.1 CCC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL222159 84200 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 3 5.1 CCC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11050306 60007 0 None -1 2 Rat 8.7 pKi = 8.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 60007 0 None -1 2 Rat 8.7 pKi = 8.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
659 2854 13 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
9831083 2854 13 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
CHEMBL273869 2854 13 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
9961595 64273 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 687 10 1 7 4.4 CC(C)N1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc(NCC(c4ccccc4)c4ccccc4)c(C(=O)N4CCOCC4)c3)CC2)CC1 10.1021/jm049747g
CHEMBL181695 64273 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 687 10 1 7 4.4 CC(C)N1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc(NCC(c4ccccc4)c4ccccc4)c(C(=O)N4CCOCC4)c3)CC2)CC1 10.1021/jm049747g
11377529 66371 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 706 19 2 8 3.8 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c(C(=O)N2CCOCC2)c1 10.1021/jm049747g
CHEMBL185551 66371 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 706 19 2 8 3.8 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c(C(=O)N2CCOCC2)c1 10.1021/jm049747g
11479448 127024 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 678 17 1 8 5.0 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c([N+](=O)[O-])c2)CC1 10.1021/jm049747g
CHEMBL366294 127024 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 678 17 1 8 5.0 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c([N+](=O)[O-])c2)CC1 10.1021/jm049747g
16221229 85142 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
CHEMBL227977 85142 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
68868975 77177 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 498 13 0 7 1.4 CCN(CC)CCN1CCN(C(=O)COCCN(C)S(=O)(=O)c2c(C)cc(OC)cc2C)CC1 10.1021/jm2016057
CHEMBL2087426 77177 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 498 13 0 7 1.4 CCN(CC)CCN1CCN(C(=O)COCCN(C)S(=O)(=O)c2c(C)cc(OC)cc2C)CC1 10.1021/jm2016057
11214151 77179 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 497 11 0 6 2.8 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(C)(C)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087428 77179 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 497 11 0 6 2.8 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(C)(C)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
16102919 82753 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 6 2 4 3.7 COC(=O)c1ccccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218319 82753 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 6 2 4 3.7 COC(=O)c1ccccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10168110 77100 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 625 15 3 6 3.2 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN)CC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087030 77100 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 625 15 3 6 3.2 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN)CC2CCNCC2)c1Cl 10.1021/jm2016057
44561641 186142 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488677 186142 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44411252 76537 0 None - 1 Human 5.0 pKi = 5 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76537 0 None - 1 Human 5.0 pKi = 5 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
10875606 62744 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1788318 62744 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44455182 154848 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL403519 154848 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
11476944 77176 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 470 11 0 7 0.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087425 77176 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 470 11 0 7 0.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
24895114 178402 3 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(Cl)c2)cc1 10.1021/jm800199h
CHEMBL470693 178402 3 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(Cl)c2)cc1 10.1021/jm800199h
44455150 96970 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL269949 96970 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
44455227 94934 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 7 2 4 3.6 CCC(O)(CC)C(=O)NCc1ccc(-c2cccc(F)c2C(=O)OC)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL256793 94934 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 7 2 4 3.6 CCC(O)(CC)C(=O)NCc1ccc(-c2cccc(F)c2C(=O)OC)cc1F 10.1016/j.bmcl.2007.11.050
44570026 175744 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 508 11 2 5 3.3 O=C(O)CCNC(=O)CN(CCOc1cccc(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL459532 175744 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 508 11 2 5 3.3 O=C(O)CCNC(=O)CN(CCOc1cccc(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60142437 125385 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648466 125385 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44392025 64499 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 414 7 2 6 4.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL181968 64499 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 414 7 2 6 4.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
49863235 15061 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210752 15061 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
25181410 171648 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
CHEMBL447392 171648 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
25181410 171648 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL447392 171648 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
44402076 71351 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 456 7 3 4 4.9 CNC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196494 71351 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 456 7 3 4 4.9 CNC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
44401932 71430 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 2 6 4.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196698 71430 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 2 6 4.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
44402028 69479 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 3 5 4.2 Cc1ccnc(NCc2ccc(-c3ccccc3C(=O)O)cc2)c1NC(=O)CC#N 10.1016/j.bmcl.2005.02.077
CHEMBL193684 69479 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 3 5 4.2 Cc1ccnc(NCc2ccc(-c3ccccc3C(=O)O)cc2)c1NC(=O)CC#N 10.1016/j.bmcl.2005.02.077
16102908 141444 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 402 6 2 4 2.7 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
CHEMBL387331 141444 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 402 6 2 4 2.7 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
60141042 125416 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
CHEMBL3648497 125416 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
10388673 71059 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL195883 71059 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
57382747 126660 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 7 3.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)COC3)c(F)c2)no1 nan
CHEMBL3657610 126660 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 7 3.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)COC3)c(F)c2)no1 nan
44569937 187690 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 612 13 1 6 4.6 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1 10.1016/j.bmcl.2008.11.005
CHEMBL499999 187690 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 612 13 1 6 4.6 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1 10.1016/j.bmcl.2008.11.005
57383097 126699 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 535 10 2 6 3.5 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
CHEMBL3657649 126699 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 535 10 2 6 3.5 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
11719314 139979 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 448 7 2 4 3.7 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCC2)cc1 10.1021/jm0511280
CHEMBL381009 139979 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 448 7 2 4 3.7 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCC2)cc1 10.1021/jm0511280
16102909 82919 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(C)(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219164 82919 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(C)(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
11225601 141495 0 None -239 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141495 0 None -239 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
44401887 69501 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 389 7 2 5 4.5 CCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL193819 69501 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 389 7 2 5 4.5 CCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
49863229 15055 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210746 15055 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
49863230 15056 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210747 15056 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
12085131 77105 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 8 1 5 3.5 Cc1c(Cl)ccc(S(=O)(=O)N(C)C/C=C/C(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087036 77105 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 8 1 5 3.5 Cc1c(Cl)ccc(S(=O)(=O)N(C)C/C=C/C(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
11466010 83993 0 None -1 3 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 83993 0 None -1 3 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
10388673 71059 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL195883 71059 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60141327 125426 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
CHEMBL3648507 125426 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
11685446 186122 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186122 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
16221227 142486 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
CHEMBL389477 142486 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
11224694 92334 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243667 92334 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44570136 183022 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 12 1 5 3.7 COCCCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL480203 183022 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 12 1 5 3.7 COCCCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60142026 125371 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648453 125371 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
44455229 166330 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 363 5 2 4 2.8 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(C)(C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL428601 166330 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 363 5 2 4 2.8 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(C)(C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
44392138 122095 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 404 7 2 6 4.0 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCC1 10.1016/j.bmcl.2005.05.133
CHEMBL360260 122095 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 404 7 2 6 4.0 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCC1 10.1016/j.bmcl.2005.05.133
16221225 168802 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL442056 168802 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
44401768 125001 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 418 8 2 6 3.6 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CN(C)C)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL364670 125001 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 418 8 2 6 3.6 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CN(C)C)cc1 10.1016/j.bmcl.2005.02.077
60142963 125408 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125408 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
11293092 64929 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 421 7 2 7 3.4 COC(=O)c1ccccc1N1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL182785 64929 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 421 7 2 7 3.4 COC(=O)c1ccccc1N1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
16726096 154729 7 None -15 4 Rabbit 7.9 pKi = 7.9 Binding
Binding affinity to rabbit bradykinin B1 receptor expressed in CHO cellsBinding affinity to rabbit bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154729 7 None -15 4 Rabbit 7.9 pKi = 7.9 Binding
Binding affinity to rabbit bradykinin B1 receptor expressed in CHO cellsBinding affinity to rabbit bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
16221162 143791 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL390540 143791 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11039234 60009 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 60009 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
16102882 141034 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 438 7 2 4 2.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL384893 141034 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 438 7 2 4 2.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
44392012 64550 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 419 7 2 7 3.3 COC(=O)c1ccccc1N1CC=C(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL182177 64550 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 419 7 2 7 3.3 COC(=O)c1ccccc1N1CC=C(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
44392544 125718 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 635 19 2 7 4.5 CC(=O)c1cc(S(=O)(=O)NCCC(=O)N(CCCN(C)C)CCCN(C)C)ccc1NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
CHEMBL365009 125718 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 635 19 2 7 4.5 CC(=O)c1cc(S(=O)(=O)NCCC(=O)N(CCCN(C)C)CCCN(C)C)ccc1NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
44570139 183455 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 474 11 2 5 2.7 O=C(O)CCNC(=O)CN(CCOc1ccccc1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL482173 183455 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 474 11 2 5 2.7 O=C(O)CCNC(=O)CN(CCOc1ccccc1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
16108968 165585 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL426165 165585 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16221163 85145 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL228030 85145 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
44432176 86848 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1cc(Cl)ccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL233150 86848 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1cc(Cl)ccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
70683374 73501 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 6.8 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018864 73501 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 6.8 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
16220914 85143 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL228014 85143 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11584184 172543 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL452057 172543 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
44430680 141544 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 416 6 2 4 5.0 N#CC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388029 141544 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 416 6 2 4 5.0 N#CC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16221056 85134 0 None 14 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85134 0 None 14 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
49863228 15051 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
CHEMBL1210742 15051 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
57382966 126686 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnn4)COC3)c(F)c2)no1 nan
CHEMBL3657636 126686 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnn4)COC3)c(F)c2)no1 nan
11422305 63428 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 638 19 2 8 4.2 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL180143 63428 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 638 19 2 8 4.2 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
70691811 73494 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 489 5 2 4 4.5 O=C(CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccccc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018857 73494 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 489 5 2 4 4.5 O=C(CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccccc1 10.1016/j.bmcl.2012.03.065
10166801 102310 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 569 8 1 5 6.3 O=C(CCCN1C(=O)CN=C(C2CCCCC2)c2ccccc21)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1021/jm034020y
CHEMBL30525 102310 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 569 8 1 5 6.3 O=C(CCCN1C(=O)CN=C(C2CCCCC2)c2ccccc21)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1021/jm034020y
44392040 172311 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL451549 172311 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
57343016 77167 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 480 10 1 6 1.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(F)cccc1F 10.1021/jm2016057
CHEMBL2087416 77167 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 480 10 1 6 1.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(F)cccc1F 10.1021/jm2016057
16108963 161418 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415849 161418 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
44430679 142021 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 421 7 2 4 5.1 COC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL389094 142021 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 421 7 2 4 5.1 COC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
60142025 125370 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648452 125370 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
44569938 188312 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL507546 188312 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
57399671 69226 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69226 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
24895455 185842 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 479 8 3 5 4.0 O=C(NCC1CCCO1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487621 185842 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 479 8 3 5 4.0 O=C(NCC1CCCO1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
12085130 77103 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 8 1 5 3.3 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087034 77103 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 8 1 5 3.3 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
60142835 125403 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648484 125403 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
23627520 73507 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018870 73507 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
16108965 160783 0 None 1000 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL412552 160783 0 None 1000 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
44561643 185066 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185066 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
60143098 125411 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648492 125411 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
44570137 190383 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 518 11 2 7 2.4 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL518616 190383 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 518 11 2 7 2.4 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
11604201 72984 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 422 7 2 4 3.2 COC(=O)c1ccccc1-c1ccc(CNC(=O)[C@@H](C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL201310 72984 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 422 7 2 4 3.2 COC(=O)c1ccccc1-c1ccc(CNC(=O)[C@@H](C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
49863234 15060 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210751 15060 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11526891 188291 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188291 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
57396212 69222 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccc(Cl)cc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934261 69222 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccc(Cl)cc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
11676747 87463 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 449 7 2 5 4.7 COC(=O)C1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233873 87463 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 449 7 2 5 4.7 COC(=O)C1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16102897 86811 13 None -1737 3 Rat 5.8 pKi = 5.8 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86811 13 None -1737 3 Rat 5.8 pKi = 5.8 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
70693872 73499 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 587 8 1 6 4.2 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCN1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018862 73499 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 587 8 1 6 4.2 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCN1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2012.03.065
11555599 173028 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL453338 173028 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
56835163 69225 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69225 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411355 76451 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 6 1 6 3.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206935 76451 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 6 1 6 3.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11039234 60009 0 None -1 2 Rat 7.8 pKi = 7.8 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 60009 0 None -1 2 Rat 7.8 pKi = 7.8 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
16108966 83959 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221925 83959 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16108962 141188 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385740 141188 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
60142836 125404 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
CHEMBL3648485 125404 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
11421944 85120 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227778 85120 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
88925471 125384 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648465 125384 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
44430681 87570 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccccc2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234296 87570 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccccc2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
11071992 60006 0 None -3 2 Rat 7.7 pKi = 7.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 60006 0 None -3 2 Rat 7.7 pKi = 7.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
60142834 125402 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
CHEMBL3648483 125402 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
57401425 69220 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69220 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411050 76850 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 453 7 1 6 4.3 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207922 76850 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 453 7 1 6 4.3 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895252 185714 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL1203967 185714 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487444 185714 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
60143099 125412 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648493 125412 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
11519239 185178 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486640 185178 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57383009 126690 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 8 2 4 5.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657640 126690 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 8 2 4 5.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
16108964 141189 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385741 141189 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
24970503 169210 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 576 10 2 7 3.4 COc1cc2c(cc1OC)C(CC(=O)NCCc1ccc(C3=NCCN3)cc1)N(S(=O)(=O)c1ccc(C)cc1)CC2 10.1016/j.ejmech.2007.10.030
CHEMBL443900 169210 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 576 10 2 7 3.4 COc1cc2c(cc1OC)C(CC(=O)NCCc1ccc(C3=NCCN3)cc1)N(S(=O)(=O)c1ccc(C)cc1)CC2 10.1016/j.ejmech.2007.10.030
44392068 64480 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 442 7 2 7 4.8 Cc1noc([C@H]2CC=CC[C@@H]2c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)n1 10.1016/j.bmcl.2005.05.133
CHEMBL181961 64480 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 442 7 2 7 4.8 Cc1noc([C@H]2CC=CC[C@@H]2c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)n1 10.1016/j.bmcl.2005.05.133
44430686 141546 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 452 6 2 4 5.3 N#CC1(c2cccc(F)c2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388031 141546 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 452 6 2 4 5.3 N#CC1(c2cccc(F)c2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16102897 86811 13 None 7 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to rhesus monkey bradykinin B1 receptorBinding affinity to rhesus monkey bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86811 13 None 7 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to rhesus monkey bradykinin B1 receptorBinding affinity to rhesus monkey bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11259064 136602 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 433 6 2 5 5.4 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C#N)cc1 10.1021/jm049394l
CHEMBL374779 136602 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 433 6 2 5 5.4 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C#N)cc1 10.1021/jm049394l
10128103 144990 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL391491 144990 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16041612 172399 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172399 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
24895454 186016 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 522 10 3 6 3.6 O=C(NCCCN1CCOCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487876 186016 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 522 10 3 6 3.6 O=C(NCCCN1CCOCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
57342336 77104 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 526 10 1 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087035 77104 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 526 10 1 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
16726096 154729 7 None -2 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity to rat bradykinin B1 receptor expressed in CHO cellsBinding affinity to rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154729 7 None -2 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity to rat bradykinin B1 receptor expressed in CHO cellsBinding affinity to rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
57383010 126691 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 11 2.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657641 126691 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 11 2.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
44392156 64611 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.3 COC(=O)C1CCCCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182275 64611 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.3 COC(=O)C1CCCCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
44411095 168253 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 7 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL437704 168253 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 7 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
70695989 73498 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.4 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018861 73498 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.4 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57383008 126689 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 9 2 6 4.8 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657639 126689 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 9 2 6 4.8 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
44455492 94635 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 7 2 3 6.0 CC(C)Oc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL255325 94635 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 7 2 3 6.0 CC(C)Oc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
57382748 126661 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 7 2 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccno4)COC3)c(F)c2)no1 nan
CHEMBL3657611 126661 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 7 2 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccno4)COC3)c(F)c2)no1 nan
44432207 86809 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 5 5.5 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
CHEMBL232933 86809 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 5 5.5 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
57382749 126662 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 9 3.7 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657612 126662 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 9 3.7 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
16102884 82743 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 472 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218267 82743 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 472 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
57523216 125395 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648476 125395 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
57382746 126659 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 639 7 2 7 5.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cc(F)cc(C(F)(F)F)c4)COC3)c(F)c2)no1 nan
CHEMBL3657609 126659 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 639 7 2 7 5.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cc(F)cc(C(F)(F)F)c4)COC3)c(F)c2)no1 nan
57382835 126669 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 9 2 7 4.0 C[C@@H](NC(=O)C1(NC(=O)c2cncnc2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657619 126669 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 9 2 7 4.0 C[C@@H](NC(=O)C1(NC(=O)c2cncnc2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
44432220 86773 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 521 6 2 5 4.4 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232750 86773 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 521 6 2 5 4.4 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
24895550 173353 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173353 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
11456015 154838 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 582 10 2 6 5.8 C[C@@H](NC(=O)C1(NC(=O)c2cc(C3CC3)on2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL403434 154838 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 582 10 2 6 5.8 C[C@@H](NC(=O)C1(NC(=O)c2cc(C3CC3)on2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587041 187294 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL496459 187294 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
71454502 78602 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 428 7 2 6 4.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113091 78602 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 428 7 2 6 4.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
11363856 84114 0 None -5 3 Rabbit 8.6 pKi = 8.6 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84114 0 None -5 3 Rabbit 8.6 pKi = 8.6 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
44411442 139906 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 5.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380920 139906 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 5.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102885 82796 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 454 7 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218552 82796 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 454 7 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)Cl)CC2)c(F)c1 10.1021/jm061094b
57342845 77160 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.4 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C(F)(F)F 10.1021/jm2016057
CHEMBL2087409 77160 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.4 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C(F)(F)F 10.1021/jm2016057
44411353 75214 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL204562 75214 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
70691814 73505 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
CHEMBL2018868 73505 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
16102881 82944 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219309 82944 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
60142027 125372 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648454 125372 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
16221054 141540 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
CHEMBL387982 141540 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
11452874 151857 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL397037 151857 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44402075 71665 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1021/jm049394l
CHEMBL197462 71665 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1021/jm049394l
44402075 71665 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL197462 71665 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
24895354 178312 3 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1 10.1021/jm800199h
CHEMBL469875 178312 3 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1 10.1021/jm800199h
16726096 154729 7 None -239 4 Dog 6.7 pKi = 6.7 Binding
Binding affinity to dog bradykinin B1 receptor expressed in CHO cellsBinding affinity to dog bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 154729 7 None -239 4 Dog 6.7 pKi = 6.7 Binding
Binding affinity to dog bradykinin B1 receptor expressed in CHO cellsBinding affinity to dog bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
49863232 15058 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210749 15058 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44569935 168925 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL443207 168925 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
16221160 96821 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL268911 96821 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
44569939 178153 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 580 12 1 7 4.2 COc1ccccc1CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL468492 178153 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 580 12 1 7 4.2 COc1ccccc1CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60141184 125420 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648501 125420 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
44410972 76925 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCOCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208086 76925 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCOCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60142305 125383 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648464 125383 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44411349 139834 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 550 6 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)C(C)(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380834 139834 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 550 6 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)C(C)(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895450 190797 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 423 6 2 4 3.8 CN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL519247 190797 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 423 6 2 4 3.8 CN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895186 185595 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 409 6 3 4 3.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487263 185595 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 409 6 3 4 3.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
60142024 125369 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648451 125369 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
10311064 77630 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL2096845 77630 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44570138 183023 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 456 8 1 4 3.3 CNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL480204 183023 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 456 8 1 4 3.3 CNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
44411360 76529 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 7 1 7 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(S(C)(=O)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206982 76529 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 7 1 7 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(S(C)(=O)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895351 189266 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2)cc1 10.1021/jm800199h
CHEMBL516783 189266 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2)cc1 10.1021/jm800199h
11284458 140058 2 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
CHEMBL381366 140058 2 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
11670860 185180 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486641 185180 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
60141039 125414 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648495 125414 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
11376509 63985 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 567 16 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL181098 63985 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 567 16 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
44401703 132957 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 7 2 5 4.7 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)C(C)C)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL370704 132957 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 7 2 5 4.7 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)C(C)C)cc1 10.1016/j.bmcl.2005.02.077
70695304 77097 0 None -17 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 556 8 2 6 4.0 Cc1ccc2cccc(OCc3cc(S(=O)(=O)N4CCC[C@H]4C(=O)NCC4CCNCC4)ccc3Cl)c2n1 10.1021/jm2016057
CHEMBL2087027 77097 0 None -17 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 556 8 2 6 4.0 Cc1ccc2cccc(OCc3cc(S(=O)(=O)N4CCC[C@H]4C(=O)NCC4CCNCC4)ccc3Cl)c2n1 10.1021/jm2016057
70688994 77098 0 None 18 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 433 5 2 4 2.6 Cc1c(Cl)ccc(S(=O)(=O)N2CCC[C@H]2C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087028 77098 0 None 18 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 433 5 2 4 2.6 Cc1c(Cl)ccc(S(=O)(=O)N2CCC[C@H]2C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
60142168 125377 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648459 125377 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL2369828 207950 0 None - 1 Human 7.6 pKi = 7.6 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1c2ccccc2C[C@H]1C(=O)O 10.1021/jm990961s
60142439 125389 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648470 125389 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
24895256 185840 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 453 9 3 5 3.5 COCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487620 185840 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 453 9 3 5 3.5 COCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895184 192981 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1 10.1021/jm800199h
CHEMBL530549 192981 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1 10.1021/jm800199h
9919335 106103 1 None 489 2 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL 922 22 9 13 -2.1 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC2(CC1)C(=O)N(CC(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc3ccccc3N(CC(=O)O)C1=O)CN2CCc1ccccc1 10.1021/jm990962k
CHEMBL3142392 106103 1 None 489 2 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL 922 22 9 13 -2.1 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC2(CC1)C(=O)N(CC(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc3ccccc3N(CC(=O)O)C1=O)CN2CCc1ccccc1 10.1021/jm990962k
44430684 87616 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2cccc(C(F)(F)F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234512 87616 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2cccc(C(F)(F)F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44455108 154605 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL402114 154605 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
16221164 161197 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL413786 161197 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
57382878 126675 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 521 8 2 8 2.7 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)COC1 nan
CHEMBL3657625 126675 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 521 8 2 8 2.7 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)COC1 nan
44392045 131261 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.3 COC(=O)c1ccccc1C1=CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL369307 131261 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.3 COC(=O)c1ccccc1C1=CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
44411347 76535 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 7 1 6 3.8 C#CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207000 76535 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 7 1 6 3.8 C#CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
16221053 141817 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL388720 141817 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
11575578 73589 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 430 7 2 6 2.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1021/jm0511280
CHEMBL202090 73589 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 430 7 2 6 2.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1021/jm0511280
60141181 125417 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648498 125417 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
44391977 122258 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 403 7 2 7 3.4 COC(=O)c1cccn1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL360500 122258 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 403 7 2 7 3.4 COC(=O)c1cccn1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11180748 167779 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 581 17 1 7 4.8 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(Cc2ccccc2)Cc2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL434341 167779 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 581 17 1 7 4.8 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(Cc2ccccc2)Cc2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
24895111 176146 3 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2F)cc1 10.1021/jm800199h
CHEMBL460045 176146 3 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2F)cc1 10.1021/jm800199h
44411080 165673 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 556 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(Cc4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL426681 165673 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 556 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(Cc4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60141326 125425 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648506 125425 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
16220987 78702 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL2113274 78702 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
44411071 76528 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 530 8 1 6 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206975 76528 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 530 8 1 6 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895182 178286 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2F)cc1 10.1021/jm800199h
CHEMBL469675 178286 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2F)cc1 10.1021/jm800199h
10187347 192757 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL52498 192757 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44411252 76537 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76537 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57390932 69215 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69215 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
60142962 125407 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
CHEMBL3648488 125407 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
88574592 126676 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 588 10 2 8 4.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657626 126676 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 588 10 2 8 4.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
11225601 141495 0 None -6 3 Rabbit 8.5 pKi = 8.5 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 141495 0 None -6 3 Rabbit 8.5 pKi = 8.5 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
60142570 125394 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
CHEMBL3648475 125394 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
23627396 73504 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018867 73504 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57342494 77162 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1cccc(Cl)c1Cl 10.1021/jm2016057
CHEMBL2087411 77162 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1cccc(Cl)c1Cl 10.1021/jm2016057
57383011 126692 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 598 10 2 7 4.6 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
CHEMBL3657642 126692 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 598 10 2 7 4.6 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
44411368 76799 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.8 C/C=C/CN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207800 76799 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.8 C/C=C/CN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
11331054 15052 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210743 15052 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68869570 77171 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 9 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CC4CCC(C3)N4C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087420 77171 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 9 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CC4CCC(C3)N4C)CC2)c(C)c1 10.1021/jm2016057
44411457 76359 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 8 1 6 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206519 76359 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 8 1 6 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411051 76721 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 494 7 1 6 4.2 CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207377 76721 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 494 7 1 6 4.2 CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
49863236 15063 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210754 15063 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
60141324 125424 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648505 125424 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57383054 126694 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 587 10 2 7 4.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657644 126694 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 587 10 2 7 4.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
44411138 165280 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4cccnc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL424868 165280 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4cccnc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11433587 15054 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210745 15054 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68867798 77180 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 11 0 6 2.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087429 77180 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 11 0 6 2.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142703 125396 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648477 125396 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60141182 125418 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648499 125418 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
44430694 87493 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 500 7 2 5 5.9 N#CC1(c2ccccc2OC(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233887 87493 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 500 7 2 5 5.9 N#CC1(c2ccccc2OC(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44430692 87492 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 450 6 2 4 5.7 N#CC1(c2ccccc2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233886 87492 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 450 6 2 4 5.7 N#CC1(c2ccccc2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44430682 141545 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2cccc(F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388030 141545 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2cccc(F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16220918 160923 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
CHEMBL412762 160923 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
11227059 67026 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 584 8 2 7 3.8 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2cnnc2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL188617 67026 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 584 8 2 7 3.8 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2cnnc2)cc1 10.1016/j.bmcl.2004.09.074
44432223 166596 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 545 6 2 7 3.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL429074 166596 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 545 6 2 7 3.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
70687620 73502 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 624 7 1 5 5.5 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N1CCC(Cc2ccc(C3=NCCN3)cc2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018865 73502 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 624 7 1 5 5.5 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N1CCC(Cc2ccc(C3=NCCN3)cc2)CC1 10.1016/j.bmcl.2012.03.065
11341448 77183 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 524 10 0 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087432 77183 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 524 10 0 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
60142706 125399 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648480 125399 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
44430687 87618 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2ccc(Cl)c(Cl)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234514 87618 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2ccc(Cl)c(Cl)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
49863237 15064 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210755 15064 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11454567 77181 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 485 11 1 7 1.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(O)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087430 77181 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 485 11 1 7 1.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(O)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142167 125376 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
CHEMBL3648458 125376 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
11284303 66010 0 None -2 2 Human 5.5 pKi = 5.5 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL185068 66010 0 None -2 2 Human 5.5 pKi = 5.5 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
16220913 85126 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227828 85126 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11467345 161402 0 None 489 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415629 161402 0 None 489 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57403175 69219 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934258 69219 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44401834 123500 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 442 7 3 4 4.6 CNC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL362974 123500 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 442 7 3 4 4.6 CNC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60142566 125388 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648469 125388 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
24895353 178375 3 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)c(F)c2)cc1 10.1021/jm800199h
CHEMBL470487 178375 3 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)c(F)c2)cc1 10.1021/jm800199h
11757682 121526 0 None -1949 4 Rat 7.5 pKi = 7.5 Binding
Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 121526 0 None -1949 4 Rat 7.5 pKi = 7.5 Binding
Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
44411392 140725 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 524 6 1 7 4.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)OC)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL383089 140725 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 524 6 1 7 4.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)OC)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
49863227 15050 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210741 15050 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68869351 77170 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087419 77170 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
44569936 172614 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL452238 172614 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
11495796 73188 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL201717 73188 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
44391980 64685 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.4 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCCC1 10.1016/j.bmcl.2005.05.133
CHEMBL182331 64685 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.4 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCCC1 10.1016/j.bmcl.2005.05.133
11442712 84802 0 None -89 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 84802 0 None -89 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
11386138 84020 0 None -50 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84020 0 None -50 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44392010 65528 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 435 7 2 7 3.7 COC(=O)c1ccccc1N1CCC(C)(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL183538 65528 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 435 7 2 7 3.7 COC(=O)c1ccccc1N1CCC(C)(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
60142569 125393 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648474 125393 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
60142837 125405 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648486 125405 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
16220988 85110 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
CHEMBL227697 85110 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
25181410 171648 1 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
CHEMBL447392 171648 1 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
60142166 125375 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
CHEMBL3648457 125375 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
44392040 172311 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL451549 172311 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
60142165 125374 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3648456 125374 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
123884 2274 13 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
641 2274 13 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
CHEMBL80472 2274 13 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
16108967 83926 0 None 147 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221691 83926 0 None 147 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
44391962 64404 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.4 COC(=O)c1ccccc1C1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL181899 64404 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.4 COC(=O)c1ccccc1C1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
10001334 69782 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 405 8 2 6 3.7 COCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL194018 69782 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 405 8 2 6 3.7 COCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
16220986 137092 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL375709 137092 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
57403174 69217 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69217 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
60142963 125408 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125408 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60143095 125409 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648490 125409 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
56835162 69221 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69221 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411343 76911 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 9 1 6 4.8 C=CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208006 76911 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 9 1 6 4.8 C=CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
60142704 125397 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648478 125397 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
11635365 173989 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 173989 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
57342496 77163 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(Cl)cccc1Cl 10.1021/jm2016057
CHEMBL2087412 77163 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(Cl)cccc1Cl 10.1021/jm2016057
57382921 123900 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 8 2.5 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
CHEMBL3639564 123900 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 8 2.5 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
57383055 126695 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
CHEMBL3657645 126695 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
70693873 73500 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.4 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018863 73500 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.4 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
57342849 77164 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 11 1 7 2.0 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(Cl)c1 10.1021/jm2016057
CHEMBL2087413 77164 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 11 1 7 2.0 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(Cl)c1 10.1021/jm2016057
60142303 125381 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648462 125381 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60141466 125429 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
CHEMBL3648510 125429 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
16047262 76855 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207937 76855 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60141185 125421 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648502 125421 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
11260745 77175 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087424 77175 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
46911684 15062 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210753 15062 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
57382797 126668 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 9 2 7 4.2 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657618 126668 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 9 2 7 4.2 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
23627458 73506 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018869 73506 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
16221228 165464 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL425490 165464 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
68870388 77186 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CN3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087435 77186 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CN3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
60141041 125415 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
CHEMBL3648496 125415 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
60141464 125427 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
CHEMBL3648508 125427 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
16221055 142216 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389249 142216 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
44430688 87731 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2cccc(Cl)c2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234720 87731 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2cccc(Cl)c2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
10456579 124097 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 453 8 2 7 3.1 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CS(C)(=O)=O)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL364073 124097 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 453 8 2 7 3.1 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CS(C)(=O)=O)cc1 10.1016/j.bmcl.2005.02.077
16221226 143865 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
CHEMBL390603 143865 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
11663606 192982 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL530554 192982 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11466010 83993 0 None -6 3 Rabbit 7.4 pKi = 7.4 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 83993 0 None -6 3 Rabbit 7.4 pKi = 7.4 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
60142302 125380 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648461 125380 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44569940 178154 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 11 2 5 3.1 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL468493 178154 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 11 2 5 3.1 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
57401426 69223 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934262 69223 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
49863233 15059 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210750 15059 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
57399670 69214 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69214 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
24895449 186135 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)nc2)cc1 10.1021/jm800199h
CHEMBL488626 186135 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)nc2)cc1 10.1021/jm800199h
11620980 173140 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
CHEMBL453596 173140 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
24895355 186117 3 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccncc2)cc1 10.1021/jm800199h
CHEMBL488461 186117 3 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccncc2)cc1 10.1021/jm800199h
4227718 178468 7 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL471371 178468 7 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
4227718 178468 7 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
CHEMBL471371 178468 7 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
60142833 125401 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648482 125401 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
11641218 72885 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 462 7 2 4 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCC2)cc1 10.1021/jm0511280
CHEMBL201210 72885 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 462 7 2 4 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCC2)cc1 10.1021/jm0511280
60142707 125400 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648481 125400 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
11596635 86388 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 407 6 3 4 4.5 O=C(CC(F)(F)F)Nc1cccnc1NCC1CCC(O)(c2ccccc2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL232237 86388 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 407 6 3 4 4.5 O=C(CC(F)(F)F)Nc1cccnc1NCC1CCC(O)(c2ccccc2)CC1 10.1016/j.bmcl.2007.03.059
44455147 97605 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL273156 97605 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11635364 173990 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 173990 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
70689675 73495 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 572 8 2 6 4.0 O=C(CC1COc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018858 73495 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 572 8 2 6 4.0 O=C(CC1COc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57392728 69224 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934263 69224 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
70685470 73497 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.2 O=C(CC1Cc2ccccc2CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018860 73497 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.2 O=C(CC1Cc2ccccc2CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
44430685 87617 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 474 7 2 6 4.8 COC(=O)c1cccc(C2(C#N)CCC(CNc3ncccc3NC(=O)CC(F)(F)F)CC2)c1 10.1016/j.bmcl.2007.03.059
CHEMBL234513 87617 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 474 7 2 6 4.8 COC(=O)c1cccc(C2(C#N)CCC(CNc3ncccc3NC(=O)CC(F)(F)F)CC2)c1 10.1016/j.bmcl.2007.03.059
16221111 85114 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227721 85114 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221109 143515 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL390311 143515 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
88574478 126667 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657617 126667 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
57382880 126677 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 559 7 2 10 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nnc(C)o4)COC3)c(F)c2)no1 nan
CHEMBL3657627 126677 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 559 7 2 10 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nnc(C)o4)COC3)c(F)c2)no1 nan
11620871 165482 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 165482 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411068 140381 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 512 8 1 6 4.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCF)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL382228 140381 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 512 8 1 6 4.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCF)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57382795 126666 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 516 7 2 5 3.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)COC2)c(F)c1 nan
CHEMBL3657616 126666 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 516 7 2 5 3.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)COC2)c(F)c1 nan
60141038 125413 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648494 125413 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
16220916 85135 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227879 85135 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411393 76654 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 466 6 2 6 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCNCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207122 76654 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 466 6 2 6 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCNCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16221108 85106 0 None 27 2 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85106 0 None 27 2 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
57342847 77161 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 488 11 1 7 1.6 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
CHEMBL2087410 77161 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 488 11 1 7 1.6 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
44316621 81704 0 None 57 2 Human 8.3 pKi = 8.3 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1091 24 13 15 -4.9 NC(N)=NCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL216618 81704 0 None 57 2 Human 8.3 pKi = 8.3 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1091 24 13 15 -4.9 NC(N)=NCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
24895255 184794 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 556 10 3 5 5.0 O=C(NCCCN1CCCC(F)(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL486052 184794 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 556 10 3 5 5.0 O=C(NCCCN1CCCC(F)(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
9852117 77169 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087418 77169 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
16221161 143789 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL390539 143789 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
11071992 60006 0 None 3 2 Human 8.2 pKi = 8.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 60006 0 None 3 2 Human 8.2 pKi = 8.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
71229238 125422 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648503 125422 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
68868627 77178 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 484 12 0 7 1.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087427 77178 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 484 12 0 7 1.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCCN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142438 125386 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648467 125386 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
16221057 142488 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389478 142488 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
3102216 187584 6 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 493 6 2 5 4.2 COc1ccccc1NC(=O)CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1c(C)cc(C)cc1C 10.1016/j.bmcl.2008.07.055
CHEMBL498679 187584 6 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 493 6 2 5 4.2 COc1ccccc1NC(=O)CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1c(C)cc(C)cc1C 10.1016/j.bmcl.2008.07.055
57382963 126683 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nccn4C)COC3)c(F)c2)no1 nan
CHEMBL3657633 126683 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nccn4C)COC3)c(F)c2)no1 nan
44455255 94991 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 335 5 2 4 2.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CO)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL257053 94991 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 335 5 2 4 2.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CO)c(F)c1 10.1016/j.bmcl.2007.11.050
44411153 140699 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL382909 140699 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11553268 74046 0 None - 1 Human 4.3 pKi = 4.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 408 7 2 4 2.8 COC(=O)c1ccccc1-c1ccc(CNC(=O)CNC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL202463 74046 0 None - 1 Human 4.3 pKi = 4.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 408 7 2 4 2.8 COC(=O)c1ccccc1-c1ccc(CNC(=O)CNC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
60142169 125379 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648460 125379 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
44392133 65764 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 446 7 2 6 4.5 COC(=O)C1C2CCC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL183876 65764 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 446 7 2 6 4.5 COC(=O)C1C2CCC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11555433 188402 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188402 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
10282203 187833 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 600 9 2 5 6.8 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL50208 187833 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 600 9 2 5 6.8 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
24895181 178374 3 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2F)cc1 10.1021/jm800199h
CHEMBL470486 178374 3 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2F)cc1 10.1021/jm800199h
11605512 173031 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
CHEMBL453340 173031 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
44587207 187565 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL498489 187565 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
44455074 154992 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL404246 154992 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
70688995 77099 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 611 14 5 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087029 77099 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 611 14 5 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
44455256 166521 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 361 5 2 4 2.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(O)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL428954 166521 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 361 5 2 4 2.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(O)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
11691896 186123 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488512 186123 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
60142961 125406 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648487 125406 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
11466010 83993 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 83993 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
44402298 71292 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 470 7 3 4 5.5 CNC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196352 71292 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 470 7 3 4 5.5 CNC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60142028 125373 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648455 125373 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60143096 125410 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648491 125410 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60141323 125423 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648504 125423 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
70691812 73496 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.6 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018859 73496 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.6 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
11526655 185985 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL487823 185985 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57382793 126664 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 502 6 2 5 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)COC2)c(F)c1 nan
CHEMBL3657614 126664 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 502 6 2 5 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)COC2)c(F)c1 nan
11953367 16890 12 None -19 2 Mouse 8.2 pKi = 8.2 Binding
Binding affinity to mouse bradykinin B1 receptorBinding affinity to mouse bradykinin B1 receptor
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
CHEMBL1254771 16890 12 None -19 2 Mouse 8.2 pKi = 8.2 Binding
Binding affinity to mouse bradykinin B1 receptorBinding affinity to mouse bradykinin B1 receptor
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
60142567 125391 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648472 125391 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142440 125387 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648468 125387 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
16221283 85107 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227655 85107 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
57342852 77166 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 492 10 1 6 2.3 Cc1c(Cl)cccc1S(=O)(=O)N(C)CCOCC(=O)N(C)Cc1ccc(C2=NCCN2)cc1 10.1021/jm2016057
CHEMBL2087415 77166 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 492 10 1 6 2.3 Cc1c(Cl)cccc1S(=O)(=O)N(C)CCOCC(=O)N(C)Cc1ccc(C2=NCCN2)cc1 10.1021/jm2016057
44430683 87571 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccc(F)cc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234297 87571 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccc(F)cc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
54585539 61871 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777973 61871 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
44411338 137901 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 7 1 5 5.9 COC(=O)c1c(Cl)cccc1-c1ccc(CNc2cc(CN3CCCCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL377440 137901 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 7 1 5 5.9 COC(=O)c1c(Cl)cccc1-c1ccc(CNc2cc(CN3CCCCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411245 76942 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 542 7 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208210 76942 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 542 7 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102922 83818 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1F 10.1021/jm061094b
CHEMBL220978 83818 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1F 10.1021/jm061094b
70691813 73073 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 7.0 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2016601 73073 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 7.0 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
11546560 73588 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm0511280
CHEMBL202089 73588 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm0511280
60141183 125419 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
CHEMBL3648500 125419 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
12085225 77165 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 10 1 7 1.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C#N 10.1021/jm2016057
CHEMBL2087414 77165 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 10 1 7 1.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C#N 10.1021/jm2016057
56594373 65552 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1835762 65552 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
56594241 65546 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65546 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44411252 76537 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76537 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895112 176147 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2)cc1 10.1021/jm800199h
CHEMBL460046 176147 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2)cc1 10.1021/jm800199h
12085129 77102 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 9 1 5 3.7 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087033 77102 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 9 1 5 3.7 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
44455181 96990 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL270017 96990 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
60142568 125392 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648473 125392 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
24970501 187549 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 516 8 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCc3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.ejmech.2007.10.030
CHEMBL498394 187549 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 516 8 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCc3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.ejmech.2007.10.030
11281533 64746 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 64746 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
60141465 125428 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648509 125428 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
57383096 126698 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 589 9 2 8 4.4 Cc1nnsc1C(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
CHEMBL3657648 126698 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 589 9 2 8 4.4 Cc1nnsc1C(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
71456247 78597 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 457 7 2 5 5.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113085 78597 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 457 7 2 5 5.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
16102897 86811 13 None -7 3 Rabbit 8.1 pKi = 8.1 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 86811 13 None -7 3 Rabbit 8.1 pKi = 8.1 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
60142963 125408 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125408 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
44432178 86969 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1noc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1016/j.bmcl.2007.04.040
CHEMBL233350 86969 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1noc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1016/j.bmcl.2007.04.040
16220990 85121 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227786 85121 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
659 2854 13 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2854 13 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2854 13 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
44411091 76749 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 465 6 1 5 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207539 76749 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 465 6 1 5 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895352 178605 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(Cl)cc2)cc1 10.1021/jm800199h
CHEMBL472303 178605 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(Cl)cc2)cc1 10.1021/jm800199h
44455148 96969 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 377 6 2 4 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL269948 96969 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 377 6 2 4 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
24895183 187711 3 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccnc2)cc1 10.1021/jm800199h
CHEMBL500312 187711 3 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccnc2)cc1 10.1021/jm800199h
44411252 76537 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76537 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11375297 92140 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL243467 92140 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
44392113 65535 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 432 7 2 6 4.2 COC(=O)C1C2CCC(C2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL183562 65535 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 432 7 2 6 4.2 COC(=O)C1C2CCC(C2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11670114 72742 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 7 2 4 4.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCCC2)cc1 10.1021/jm0511280
CHEMBL201107 72742 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 7 2 4 4.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCCC2)cc1 10.1021/jm0511280
57390933 69216 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934255 69216 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220989 141967 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL389054 141967 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
49863231 15057 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210748 15057 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
10187167 77187 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 539 9 2 6 2.0 Cc1c(Cl)ccc(S(=O)(=O)N(C)CC(=O)NCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087436 77187 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 539 9 2 6 2.0 Cc1c(Cl)ccc(S(=O)(=O)N(C)CC(=O)NCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
44411372 76948 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 506 8 1 6 4.4 C=CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208241 76948 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 506 8 1 6 4.4 C=CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
659 2854 13 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2854 13 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2854 13 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
16220915 85109 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227690 85109 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
57383056 126696 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 9 2 8 3.9 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
CHEMBL3657646 126696 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 9 2 8 3.9 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
23627583 73511 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018874 73511 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
16221110 84611 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL224071 84611 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411092 76683 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207178 76683 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11363856 84114 0 None -162 3 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84114 0 None -162 3 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
44411297 77008 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208538 77008 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57382964 126684 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cn(C)cn4)COC3)c(F)c2)no1 nan
CHEMBL3657634 126684 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cn(C)cn4)COC3)c(F)c2)no1 nan
44316620 2090 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
656 2090 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
CHEMBL408846 2090 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
44455107 97545 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 6 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL272791 97545 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 6 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
16220917 165782 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL427279 165782 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411252 76537 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76537 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
12085227 77168 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 528 11 1 7 2.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccc(OC(F)(F)F)cc1 10.1021/jm2016057
CHEMBL2087417 77168 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 528 11 1 7 2.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccc(OC(F)(F)F)cc1 10.1021/jm2016057
10281725 965 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
666 965 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
CHEMBL299164 965 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
44587206 187564 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL498488 187564 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
44402279 70834 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 8 2 5 4.9 CCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL195617 70834 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 8 2 5 4.9 CCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
44455145 97463 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 5 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL272491 97463 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 5 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
44411134 76949 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCN(C)CC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208247 76949 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCN(C)CC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411135 76950 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 451 7 1 5 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208248 76950 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 451 7 1 5 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
23627523 73509 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018872 73509 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
60142304 125382 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648463 125382 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142441 125390 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648471 125390 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142705 125398 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
CHEMBL3648479 125398 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
44411058 76844 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 536 9 1 6 5.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207913 76844 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 536 9 1 6 5.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11752335 77182 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087431 77182 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
25181411 188704 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL512111 188704 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
44455228 94979 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 471 5 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(O)(C(F)(F)F)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL257016 94979 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 471 5 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(O)(C(F)(F)F)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
10120979 101143 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccccn4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL298860 101143 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccccn4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
122227 1351 27 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
3825 1351 27 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
644 1351 27 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
CHEMBL264100 1351 27 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
119376 1811 41 3H-BRADYKININ -54954 26 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
247 1811 41 3H-BRADYKININ -54954 26 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
CHEMBL33884 1811 41 3H-BRADYKININ -54954 26 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
44208932 140176 6 UNDEFINED -120226 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
CHEMBL381689 140176 6 UNDEFINED -120226 37 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
None 214358 0 3H-BRADYKININ -1 13 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 164 3 1 3 0.8 C1CNC1COC2=CN=CC=C2 None
122173054 216012 0 None 1 6 Rat 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 1304 30 18 17 -4.4 N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@H]3CCCC[C@H]3C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2 None
122173054 216012 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 1304 30 18 17 -4.4 N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@H]3CCCC[C@H]3C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2 None
3812 709 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
439201 709 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
649 709 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL406291 709 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
DB12126 709 37 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123643 3775 0 None -1 2 Rat 5.1 pKi = 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
639 3775 0 None -1 2 Rat 5.1 pKi = 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3812 709 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
439201 709 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
649 709 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL406291 709 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB12126 709 37 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123643 3775 0 None 1 2 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
639 3775 0 None 1 2 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
164234 3422 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
164234 3422 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8996175
643 3422 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
643 3422 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8996175
5311111 2144 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8302267
5311111 2144 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
650 2144 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8302267
650 2144 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
5311111 2144 0 None -25 3 Rat 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
650 2144 0 None -25 3 Rat 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3812 709 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
439201 709 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
649 709 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL406291 709 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
DB12126 709 37 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
662 3624 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
9853583 3624 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
CHEMBL2021721 3624 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
642 2276 17 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
642 2276 17 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL384721 2276 17 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL384721 2276 17 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
661 3227 0 None 63 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
654 560 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
654 560 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
654 560 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
655 561 0 None - 1 Human 9.7 pKi = 9.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16368899
655 561 0 None - 1 Human 9.7 pKi = 9.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
122227 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
122227 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
122227 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
122227 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
3825 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3825 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
3825 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
3825 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
644 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
644 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
644 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
644 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL264100 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL264100 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
CHEMBL264100 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL264100 1351 27 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
658 2828 0 None 3981 2 Human 10.2 pKi None 10.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
665 959 2 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
9916412 959 2 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
CHEMBL189123 959 2 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
5128451 1353 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
5128451 1353 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
646 1353 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
646 1353 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
100978427 1352 0 None -35 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
645 1352 0 None -35 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
155817380 1366 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
648 1366 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
102061602 1365 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
647 1365 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
651 260 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
667 1942 32 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
71364 1942 32 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL2028850 1942 32 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB06196 1942 32 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123884 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123884 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
123884 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123884 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
123884 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
641 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
641 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
641 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
641 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
641 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL80472 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL80472 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
CHEMBL80472 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL80472 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
CHEMBL80472 2274 13 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
653 559 0 None -316 4 Mouse 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
667 1942 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
667 1942 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
71364 1942 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
71364 1942 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL2028850 1942 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL2028850 1942 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
DB06196 1942 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB06196 1942 32 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
101607591 2399 0 None - 1 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
637 2399 0 None - 1 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
3081308 2827 0 None -15 2 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
657 2827 0 None -15 2 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
44316620 2090 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
656 2090 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
CHEMBL408846 2090 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
665 959 2 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
9916412 959 2 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
CHEMBL189123 959 2 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
164234 3422 0 None 35 2 Rat 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
643 3422 0 None 35 2 Rat 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
100978427 1352 0 None 35 2 Rat 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
645 1352 0 None 35 2 Rat 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
661 3227 0 None -63 2 Mouse 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
663 1350 0 None -1 3 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
663 1350 0 None -1 3 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
663 1350 0 None -1 3 Rat 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
640 3570 0 None - 1 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123884 2274 13 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
641 2274 13 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL80472 2274 13 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
663 1350 0 None 1 3 Mouse 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
653 559 0 None -15 4 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856115
653 559 0 None -15 4 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
5311111 2144 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
5311111 2144 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
5311111 2144 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
650 2144 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
650 2144 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
650 2144 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
659 2854 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
659 2854 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
9831083 2854 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
9831083 2854 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
CHEMBL273869 2854 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
CHEMBL273869 2854 13 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
642 2276 17 None -12 2 Mouse 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL384721 2276 17 None -12 2 Mouse 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
20814785 3154 0 None - 1 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 11 3 7 6.6 Clc1ccc(cc1)CNC(=O)C(Nc1nc(NCc2cccc(c2)Cl)nc(c1)n1ccnc1)CC1CCCCC1 10596850
660 3154 0 None - 1 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 11 3 7 6.6 Clc1ccc(cc1)CNC(=O)C(Nc1nc(NCc2cccc(c2)Cl)nc(c1)n1ccnc1)CC1CCCCC1 10596850
654 560 0 None -17 3 Mouse 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
123884 2274 13 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
641 2274 13 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL80472 2274 13 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
654 560 0 None -10 3 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
122227 1351 27 None -6 3 Rat 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3825 1351 27 None -6 3 Rat 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
644 1351 27 None -6 3 Rat 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL264100 1351 27 None -6 3 Rat 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
122227 1351 27 None -6 3 Mouse 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
3825 1351 27 None -6 3 Mouse 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
644 1351 27 None -6 3 Mouse 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL264100 1351 27 None -6 3 Mouse 8.8 pKi None 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
10281725 965 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
666 965 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
CHEMBL299164 965 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
10281725 965 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
666 965 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
CHEMBL299164 965 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
5128451 1353 0 None 2818 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
646 1353 0 None 2818 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
652 556 0 None - 1 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16368899
636 3569 0 None - 1 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052